Home   Chapter Home   Jobs   Conferences   Fellowships   Books

Advertisement

Adrenal gland and paraganglia


Reviewers: See individual topics
Revised: 23 March 2011, last major update February 2005

Copyright: (c) 2002-2011, PathologyOutlines.com, Inc.

Printer Friendly Version

 

Table of Contents-Adrenal gland

Primary references, anatomy, embryology, histology, grossing, adrenal cortex-physiology

Congenital anomalies: accessory adrenal tissue, adrenal cytomegaly, adrenal hypoplasia, adrenal union or adhesion, Beckwith-Wiedemann syndrome, congenital adrenal hyperplasia, hereditary ACTH unresponsiveness, storage diseases

Adrenal insufficiency: primary-general, secondary, Addison’s disease, amyloidosis, autoimmune adrenalitis, drugs, infections, isolated mineralocorticoid deficiency, polyglandular autoimmune syndromes, radiation, Waterhouse-Friderichsen syndrome,

Adrenal hyperfunction/hyperplasia: general, Cushing’s syndrome, hyperaldosteronism, acquired hyperplasia, macronodular hyperplasia, micronodular hyperplasia, pigmented hyperplasia, unilateral hyperplasia

Adrenocortical adenoma: children, adenoma-general, oncocytoma, corticomedullary mixed tumor

Other benign cortical lesions: adenomatoid, cysts, focal adrenalitis, hemangioma, malakoplakia, massive macronodular adrenocortical disease, myelolipoma, ovarian thecal metaplasia, solitary fibrous tumor

Adrenocortical carcinoma: general, staging, features to report

 

Adrenal medulla: physiology, hyperplasia, tumors-general, malignant melanotic tumors, pheochromocytoma

Neuroblastic tumors: general, ganglioneuroblastoma, ganglioneuroma, neuroblastoma, staging, prognostic factors, grossing

 

Other adrenal malignancies: angiosarcoma, Ewing’s/PNET, leiomyosarcoma, lymphoma, metastases, plasmacytoma

 

Paraganglia: general, hyperplasia, paraganglioma, paraganglioma-report

 

Primary references

top

 

American Journal of Surgical Pathology (AJSP), March 1977 to February 2005

Archives of Pathology and Laboratory Medicine (Archives), January 1976 to February 2005

Human Pathology (Hum Path), March 1970 to November 2004

Modern Pathology (Mod Path), Jan 1988 to February 2005

Atlas of Nontumor Pathology, Series I: Endocrine Disease; AFIP, 2002

Rosai, J: Ackerman’s Surgical Pathology (9th Ed); 2004

Sternberg, S: Diagnostic Surgical Pathology (4th Ed); Lippincott Williams & Wilkins, 2004

University of Pittsburgh case histories: through #417

www.Webpathology.Com

Journal search terms: adrenal, paraganglia, paraganglioma

 

Please refer to these primary references for more detailed discussions and photographs

 

Anatomy of adrenal glands

top

A composite of two neuroendocrine organs, the adrenal cortex (mesodermal, produces steroid hormones aldosterone, cortisol and testosterone) and adrenal medulla (neuroectodermal, produces catecholamines)

Also called suprarenal glands

Left and right-sided glands; left gland is crescentic and right gland is pyramidal in adults; each is 5 x 3 x 1 cm

On superiomedial kidneys in retroperitoneum

Gland has head (medial), body (middle) and tail (lateral)

Normal weight 4-6 grams each after dissection of fat; acute stress reduces lipid content and weight; prolonged stress induces hypertrophy and hyperplasia and increases weight

Has complete fibrous capsule, which may merge with capsule of kidney (either gland), and liver (right sided gland)

Cortex is bright yellow due to lipid; zona reticularis is thinner and darker

Medulla has ellipsoid shape, is gray-tan and <10% of gland volume (1% in neonates); is more prominent with cortical atrophy; majority of medulla is within head of gland

Neonatal gland is dark red-brown due to congestion, with no visible medullary tissue

Adrenal glands are supplied by aorta, inferior phrenic arteries and renal arteries; are drained by shorter right adrenal vein and longer left adrenal vein

Lymphatics only in capsule, not elsewhere

Gross drawings: (1) view from front; (2) view from behind

 

Embryology

top

By day 25 of gestation, bilateral adrenal primordium develops as cords of large polyhedral cells in coelomic epithelium medial to mesonephros and urogenital ridge

By day 45, adrenal glands enlarge to 1 mg, and primitive sympathetic cells with nerve tracts migrate to form medulla

By week 7, paraganglionic cells replicate and differentiate into chromaffin cells; primitive sympathicoblasts form neuroblastic nodules that peak at weeks 17-20 and usually regress; persistent nodules may be confused with small neuroblastomas

By week 8, each gland weighs 4 mg, with outer (definitive) cortex distinct from inner (fetal) cortex

Inner (fetal) cortex has large eosinophilic cells mixed with small nodules of primitive neuroblastic cells, represents 75% of cortical volume at birth, but then involutes due to apoptosis, with only stroma present by one year

By week 20, adrenals are larger than kidneys, and composed mostly of fetal cortex

At birth, each adrenal gland weights 5 grams

Premature, stillborn and some neonates with in utero stress have microscopic cystic changes in adrenal glands

Micro images: fetal and adult cortex

 

Histology

Adrenal cortex

top

Normal cortex in adults is 2 cm thick

Adrenal cortex anatomical zones (“gfr”):

Zona glomerulosa: just beneath the adrenal capsule; composed of small clusters and short trabeculae of relatively small, well defined cells, less cytoplasm than other cortical cells, lipid-poor, 15% of cortical volume

Zona fasciculata: forms broad band of large cells with distinct membranes arranged in cords two cells wide; cytoplasm has numerous small lipid vacuoles which may indent the central nucleus and resemble lipoblasts, 70-80% of cortical volume, lipid stores are depleted by ACTH

Zona reticularis: grossly brown; haphazardly arranged cells, smaller than zona fasciculata cells, with granular and eosinophilic cytoplasm with lipofuscin but minimal lipid; thinner than zona glomerulosa or fasciculata

Cortical extrusions: common into periadrenal fat; usually maintain attachment to adrenal gland

Cortical cuff: adrenal cortical cells around adrenal central vein and its branches

Cytology: may have aggregates of bare nuclei resembling metastatic small cell carcinoma (Mod Path 1991;4:594)

Positive stains: low molecular weight cytokeratin, alpha inhibin, MelanA/A103, bcl2, synaptophysin (weak), variable vimentin

Negative stains: chromogranin, epinephrine

Micro images: cross section; cortical layers #1; #2; #3; #4; various images (low and high power); fasciculata; reticularis; fasciculata, reticularis and medulla; reticularis lipid stain

EM: zona glomerulosa-sparse intracellular lipid, elliptical mitochondria with lamellar (plate-like) cristae; may have microvillous projections; no/rare lysosomes, lipofuscin or smooth endoplasmic reticulum

EM: zona fasciculata-round/oval mitochondria with short and long tubular cristae; prominent lipid droplets, prominent smooth endoplasmic reticulum, moderate amounts of rough endoplasmic reticulum, microvillus cytoplasmic projections, more lysosomes than zona glomerulosa

EM: zona reticularis-spherical/ovoid mitochondria with short and long tubular invaginations of inner membrane; abundant lipofuscin granules, lysosomes and microvilli; sparse lipid droplets

 

Adrenal medulla

top

Composed of neural crest cells called chromaffin cells (also called pheochromocytes, medullary cells) with a multilineage differentiation potential; also sustentacular cells

Chromaffin cells: arranged in small nests and cords separated by prominent vasculature; take up chromium salts strongly, turn brown-black after exposure to Zenker’s solution (potassium dichromate); large polygonal cells with poorly outlined borders, abundant granular and usually basophilic cytoplasm, mild variation in cell size; occasionally has PAS+ hyaline droplets

Sustentacular cells: supporting cells, spindle cells at periphery of nests of chromaffin cells; associated with rich vasculature; S100+, difficult to identify with routine staining

Ganglion cells: occasional single cells or small clusters associated with myelinated nerve bundles

Central vein: has thick wall of smooth muscle

Micro images: adrenal medulla; images 45-48 (low and high power)

Positive stains: chromogranin, synaptophysin, neurofilament, tyrosine hydroxylase, epinephrine, S100 (sustentacular cells)

Negative stains: keratin, vimentin

EM: numerous mitochondria; norepinephrine producing cells have 250 nm electron opaque neurosecretory granules, with prominent halo between granule membrane and dense core; epinephrine producing cells have 190 nm finely granular neurosecretory granules, filling the enclosing membrane and no halo; moderate amount of rough endoplasmic reticulum, interdigitating blunt cytoplasmic processes with poorly developed cell junctions; sustentacular cells have moderate amounts of rough endoplasmic reticulum and occasional lipid droplets, but no neurosecretory granules

 

Grossing

top

Protocol for examining specimens (nothing unusual compared to other specimens), Archives 2000;124:17

 

Adrenal gland-physiology

top

Adrenal cortex: synthesizes and secretes corticosteroids (mineralocorticoids, glucocorticoids and sex hormones), all derived from cholesterol

Zona glomerulosa (outer): produces mineralocorticoids (aldosterone-increases sodium and water absorption and potassium secretion)

Zona fasciculata (middle): produces glucocorticoids, some sex hormones

Zona reticularis (inner): produces estrogens and androgens, some glucocorticoids

 

Normal pathways of hormone production in adrenal cortex (via cytochrome P450 enzymes):

 

Circulating low-density lipoproteins are internalized into cortical cells, lipoproteins are hydrolyzed, producing cholesterol esters, which break down to cholesterol and free fatty acids

 

Cholesterol => 20 alpha hydroxycholesterol => (via 20,22 desmolase complex)

 

                  pregnenolone =>  progesterone - (21) => 11 deoxycorticosterone => corticosterone => aldosterone

                            | (17)                       | (17)

                   17 alpha hydroxyprogesterone => (21) - deoxycortisol => cortisol

                        |

                   dihydroxyepiandrosterone => androstenedione => estradiol 17 beta

                                                                                   |

                                                                            testosterone

 

17: 17 hydroxylase

21: 21 hydroxylase

 

Extra-adrenal regulation

top

Hypothalamic corticotropin-releasing hormone (CRH) enters hypophyseal portal system, reaches anterior pituitary gland, stimulates release of ACTH

ACTH travels in blood to adrenal cortex, is bound to cortical cell membranes, activates intracytoplasmic cyclases that form cAMP and GMP; both cortisol and ACTH inhibit release of CRH, and cortisol also inhibits secretion of ACTH

ACTH normally is secreted episodically, with more and longer episodes in early morning, and nadir in evening; this pattern causes circadian rhythm for cortisol seen in normals

Volume changes affect renin-angiotensin system, leading to aldosterone secretion

ACTH, potassium ions and aldosterone-stimulating factor also regular aldosterone synthesis

Fetal adrenal gland lacks 3 beta hydroxysteroid dehydrogenase (converts pregnenolone to progesterone); as a result produces abundant dihydroepiandosterone, but little cortisol

 

Types of hormones:

top

Autocrine: hormone binds to receptors on cell that produces it

Paracrine: hormone binds to receptors of nearby cells of a different type

Endocrine: hormone acts on target organs distant from site of synthesis

Hormones are either signaling molecules that interact with cell surface receptors or steroids that interact with intracellular receptors; signaling molecules often act via second messengers, such as cAMP, inositol triphosphate, or calcium levels

 

 

Congenital anomalies

Accessory adrenal tissue

top

Nests of adrenal tissue located away from adrenal gland

Also called heterotopia, although technically this term refers to displacement to an abnormal location, not the presence of accessory tissue elsewhere in body

Due to migration of adrenocortical primordial cells with gonads

Usually without accompanying medullary tissue; cases near celiac ganglion may also contain medullary tissue

Retroperitoneal space along urogenital ridge, beyond renal capsule in upper pole, hilum of ovary or testes, along course of spermatic cord

Present in 1% of inguinal hernia sacs

May be accompanied by malformation of epididymis

May be fused with liver or kidney and surrounded by a common capsule

May undergo same disease processes as ordinary adrenal glandular tissue

DD: metastatic renal cell carcinoma or other clear cell tumors

 

Non-adrenal tissue present in adrenal gland

Very rare (except for metastases)

Case report of benign intraadrenal thyroid tissue (Hum Path 1999;30:105)

 

Adrenal cytomegaly

top

Relatively common finding within fetal cortex in newborns, particularly premature infants (3-7%) or infants with Rh incompatibility

May be associated with Beckwith-Wiedemann syndrome

Cells do NOT represent carcinoma in situ

Case reports: occurrence in two apparently normal adults (Archives 1986;110:1072)

Gross: hyperplastic adrenal glands

Micro: numerous markedly enlarged (up to 150 microns) and bizarre polyhedral cells with eosinophilic granular cytoplasm and large hyperchromatic nuclei with pseudoinclusions in adrenal cortex; no/rare mitotic figures

DD: CMV infection (usually infants, basophilic cytoplasm, large intranuclear inclusion surrounded by a clear halo)

References: Archives 1981;105:358 (pseudoinclusions)

 

Adrenal hypoplasia

top

Congenital aplasia is very rare; found in 10% with unilateral renal agenesis

Bilateral hypoplasia is associated with anencephaly due to lack of ACTH cells; causes adrenal insufficiency

Unilateral absence occurs in 1 per 10,000 live births

May be associated with sudden infant death syndrome (Archives 1977;101:168)

Infant symptoms: weight loss, vomiting, dehydration, severe electrolyte disturbances-due to adrenal insufficiency

Primary hypoplasia: X linked, associated with mutations or deletions of DAX-1 gene at Xp21; cortex is hypoplastic, but fetal zone is intact, often has cytomegalic features; associated with hypogonadotrophic hypogonadism in young men

Miniature adult type of hypoplasia: sporadic or autosomal recessive; small glands but normal architecture

Gross: small for age adrenal glands, decreased fetal zone in newborns, scattered cytomegalic cells, cells have decreased lipid

DD: chronic exogenous glucocorticoids causes acquired hypoplasia

 

Adrenal union or adhesion

top

Rare

Adrenal union (fusion): adrenal glands are fused above the aorta with butterfly or horseshoe shape, with common connective tissue capsule and intermingling of cells; associated with midline congenital defects, including spinal dysraphism, indeterminate visceral situs, bilateral renal agenesis, Cornelia de Lange syndrome (mental and growth retardation, low set ears, antiverted nostrils, spade-like hands with short tapering fingers); normal histology

Unions also to kidney or liver in 0.4-3.0% of unselected autopsies; common capsule, but no intermingling of cells

Adrenal adhesion: adrenal gland is attached to opposite adrenal gland, but with an intervening connective tissue capsule

 

Beckwith-Wiedemann syndrome

top

Visceromegaly, gigantism, macroglossia, abdominal wall defects, craniofacial abnormalities, midfacial hypoplasia, adrenocortical hyperplasia

Incidence of 1 per 13,000 births, usually sporadic

May have brain damage due to hypoglycemia, causing mental retardation or death

May develop Wilm’s tumor, adrenocortical carcinoma, neuroblastoma, pancreatoblastoma, pheochromocytoma

Due to abnormality of 11p15.5

Gross: enlarged adrenal glands up to 16g, may be cerebriform and nodular

Gross images: large lobulated adrenal glands

Micro: bilateral cytomegaly with large and pleomorphic nuclei and cytoplasmic nuclear pseudoinclusions; also medullary hyperplasia; variable hemorrhagic macrocysts

Micro images: adrenal cytomegaly

 

Congenital adrenal hyperplasia

top

Various autosomal recessive syndromes due to enzyme deficiencies in biosynthesis of adrenal steroids, diverting production to other pathways and causing elevated ACTH levels and adrenocortical hyperplasia

No gender preference, usually presents in children, rarely in adults

Symptoms depend on specific defect; include salt wasting, virilization, adrenogenital syndrome, hypertension

Salt wasting syndrome: usually evident soon after birth (in utero, maternal kidneys maintain electrolytes and fluids); hypotension due to decreased serum sodium and increased serum potassium [from lack of aldosterone production], acidosis, cardiovascular collapse, death

Simple virilizing syndrome: easier to detect in females (clitoral hypertrophy) than males

Nonclassic virilizing syndrome: more common than simple virilizing syndrome; asymptomatic or only hirsutism

Adrenogenital syndrome: adrenal secretes excess androgens, causing changes towards adult masculinity in children or female adults; 50% occur before puberty, 80% are female; diagnosed based on elevated dehydroepiandrosterone; rarely associated with male adult feminization due to increased 17-ketosteroids

Congenital adrenal hyperplasia tumors:

Virilization in adult women is usually associated with carcinoma, particularly if Cushing’s syndrome also present

Feminization in adult men is almost always associated with carcinoma

Congenital adrenal hyperplasia is associated with testicular tumors that arise from ectopic adrenal cortical rests (Archives 2000;124:785), and rarely with similar ovarian tumors (AJSP 2001;25:1443)

 

21-hydroxylase deficiency: causes 95% of cases; incidence of 1 per 5,000 to 14,500 births (1 in 60 in the normal population are heterozygotes); block in production of aldosterone and cortisol leads to accumulation of 17-hydroxypregnenolone and its catabolite pregnanetriol, also high plasma ACTH; causes virilizing syndrome, cortisol deficiency and variable salt wasting syndrome; also Leydig cell hyperplastic nodules without Reinke crystalloids

Nonclassic 21-hydroxylase deficiency: very common autosomal recessive disorder (1% incidence in parts of US), with mild cortisol deficiency, excessive adrenal androgens, no salt wasting; usually diagnosed by early adulthood

11-beta hydroxylase deficiency: second most common form (5%), incidence of 1 per 100,000 live births; associated with increased androgens and deoxycorticosterone; causes virilization and hypertension

17-alpha hydroxylase deficiency: causes 1% of cases, all patients have female external genitalia due to increased deoxycorticosterone; also hypertension

3 beta hydroxysteroid dehydrogenase deficiency: impaired synthesis of all steroid hormones, adrenal gland is similar to normal fetus; patients present in early infancy with adrenal insufficiency, variable virilization in females

Congenital lipoid adrenal hyperplasia: very rare, low cortisol and aldosterone secretion, high levels of ACTH, FSH, LH and plasma rennin; present with severe adrenal insufficiency in neonatal period; usually die in infancy

Treatment: exogenous glucocorticoids and mineralocorticoids to provide cortisol and suppress ACTH levels, surgical correction of external genitalia

Gross: marked adrenal enlargement (15g each gland) with cerebriform appearance, tan-brown; secondary to elevated ACTH (due to reduced cortisol secretion)

Micro: diffuse cortical hyperplasia, particularly of zona reticularis-like compact cells

DD: bilateral hyperplasia due to ectopic ACTH (not grossly cerebriform, may have metastatic carcinoma, differentiate clinically)

 

Hereditary unresponsiveness to ACTH

top

Rare; due to abnormalities of ACTH receptor in adrenocortical cells

Seizures, hypoglycemia, muscle weakness, hyperpigmentation similar to Addison’s disease

Low plasma cortisol levels, increased serum ACTH

Micro: normal zona glomerulosa, atrophic zona fasciculata and reticularis

 

Storage diseases

Adrenoleukodystrophy

top

Also called Addison-Schilder’s disease

Rare, X linked recessive, affects 1 in 120,000 males

Progressive demyelination of central and peripheral nervous system (dementia, blindness, quadriplegia) and adrenocortical insufficiency

Due to mutations of adrenoleukodystrophy protein (ADLP) in peroxisomal membrane at Xq28, which cause defective oxidation of long-chain fatty acids; cholesterol esters and gangliosides accumulate in membranes of adrenal cortex, brain, other organs

Diagnosis: presence of hexacosanoate and other very long-chain saturated fatty acids in cultured skin fibroblasts

Carriers: women may have a variant form of disease or no neurologic symptoms (Archives 1987;111:151)

Adrenomyeloneuropathy: related disorder with onset in teens to 20’s; adrenal insufficiency but no neurologic disorder at initial presentation; develop weakness, spasticity and distal polyneuropathy, slowly progressive

Treatment: dietary therapy (Lorenzo’s oil) may delay neurologic progression

Gross: atrophic adrenal glands, 1-2 g

Micro: ballooning and striation of zona fasciculata and reticularis cells, often in nodules; cells may have large cortical vacuoles and clefts (representing lipid dissolved during processing); medulla unchanged

Other: cerebral white matter exhibits demyelination, inflammation, gliosis and macrophages; also abnormalities of schwann cells in peripheral nerves and Leydig cells in testis

EM: proliferation of smooth endoplasmic reticulum and trilaminar lamellar inclusions

DD: autoimmune adrenalitis (lymphocytes and no balloon cells)

 

Pompe’s disease

top

Also called type II glycogenosis

Infantile form of generalized glycogenosis, due to deficiency of lysosomal acid alpha-1,4-glucosidase

Intralysosomal glycogen storage in CNS, heart, liver, skeletal muscle, thyroid, parathyroid, pituitary, pancreatic islets; also in adrenal cortex and medulla, with severe accumulation in zona fasciculata (Archives 1985;109:921)

 

Wolman’s disease

top

Primary familial xanthomatosis

Rare, autosomal recessive lipid storage disorder

Due to deficiency of lysosomal acid lipase, causing accumulation of triglycerides and cholesterol esters in liver, spleen and adrenal glands

Usually causes death by age 6 months

Gross: markedly enlarged adrenal glands with dystrophic calcifications but normal architecture

Gross images: markedly enlarged adrenal glands

Micro: necrosis, fibrosis, calcification; zona fasciculata and reticularis cells have vacuolated cytoplasm

DD: Niemann-Pick disease, other storage diseases

 

 

Adrenal insufficiency

Primary acute adrenal insufficiency-general

top

Often insidious in onset, patients may present in shock due to increased stress

Causes:

(a) patients with chronic adrenal insufficiency (primary or secondary) and acute stress requiring immediate increase in steroids

(b) rapid withdrawal of exogenous steroids (i.e. no taper) or failure to increase steroids with acute stress

(c) massive adrenal hemorrhage destroying adrenal cortex due to anticoagulation, coagulopathy, newborns with physiologic deficiencies in prothrombin time

(d) hypotension/shock that causes mild or massive corticomedullary necrosis, including Waterhouse-Friderichsen syndrome

(e) infections that destroy substantial adrenal cortical tissue

(f) amyloidosis

(g) drugs, radiation

(h) autoimmune disorders (autoimmune adrenalitis or polyglandular autoimmune syndromes)

Patients usually live normal lives after diagnosis (depending on cause); may be at higher risk for heart failure, hypertension or osteopenia

Treatment: glucocorticoids, mineralocorticoids, IV fluids; in chronic patients, must give steroid boost during infections, prior to surgery or during pregnancy

Virtual slides: atrophy (caused not specified)

 

Secondary adrenocortical insufficiency

top

Caused by any disorder of pituitary gland which decreases ACTH production and causes adrenal cortical atrophy

Causes: pituitary macroadenoma, craniopharyngioma, tuberculosis or other infections, sarcoidosis, lymphocytic hypophysitis, head trauma, aneurysms, postpartum pituitary necrosis (Sheehan’s syndrome), pituitary apoplexy, metastases; also mutations in pro-opiomelanocortin gene

Tertiary adrenocortical insufficiency: due to disorders of hypothalamus reducing release of corticotropin releasing hormone (CRH); some  include this within secondary adrenocortical insufficiency

Similar atrophic changes are caused by exogenous steroids, which also decrease ACTH production

No hyperpigmentation since ACTH levels are low

Laboratory: serum aldosterone, sodium and potassium levels are usually normal, since they are controlled by renin-angiotensin axis, which is not under the control of ACTH; androgens and cortisol levels are low since their production is influenced by ACTH, although androgens are less affected in males since they are also produced by testis; hypoglycemia is more common than with primary adrenal insufficiency

May be associated with hypopituitarism

Treatment: exogenous ACTH; causes rise in serum cortisol levels; may also need to replace other pituitary hormones

Gross: atrophic adrenal glands with retention of architecture, often fibrotic capsule, bright yellow (due to lipid accumulation), prominent medulla

Micro: normal thickness of zona glomerulosa, thinner fasciculata and reticularis; usually no lymphoplasmacytic infiltration

 

Addison’s disease

top

Also called primary chronic adrenal insufficiency

No symptoms until 90% of cortex is compromised; affects 3-6 individuals per 100,000 population

More common in white women

Causes: autoimmune disorders, infections (Histoplasma, Coccidiodes, tuberculosis), space occupying lesions (metastases, lymphomas), hemorrhage, amyloid, sarcoid, hemochromatosis

Symptoms: progressive weakness, easy fatigability, anorexia, weight loss, depression, irritability, menstrual abnormalities, GI disturbances, hyperpigmentation (primary adrenal disease causes elevated ACTH, which stimulates melanocytes at sun-exposed areas and pressure points), small heart (due to chronic hypovolemia), hypotension; infections may precipitate an acute crisis

Laboratory: elevated ACTH levels, low cortisol levels that don’t respond to exogenous ACTH (since adrenal gland is damaged), hyponatremia, hypoglycemia, hyperkalemia, occasionally hypercalcemia

Gross: irregularly shrunken glands, may be hard to find

Virtual slides: Addison’s disease

 

Amyloidosis

top

Rarely causes cortical hypofunction, only if extensive bilateral involvement

Usually associated with systemic amyloidosis-AA type

68% of consecutive autopsies had adrenal amyloid deposits, often multinodular, probably due to aging

Gross: adrenal gland normal or enlarged; gray-yellow cut surface

Micro: typically affects zona fasciculata and reticularis, acellular salmon-pink amorphous material is present between cortical cells, which ultimately become atrophic; amyloidosis-AL type is typically deposited intravascularly

Virtual slides: amyloidosis

DD: infarction related changes

 

Autoimmune adrenalitis

top

Also called idiopathic primary adrenal insufficiency

No clinical findings until 90% of adrenal cortex is destroyed

Causes 70-90% of cases of adrenal insufficiency; usually women ages 20-50, sporadic or familial

Up to 75% have autoantibodies against adrenal cortical zones not present in normal patients; antibodies appear months to years before onset of adrenal insufficiency

50% of autoimmune cases have circulating autoantibodies to 21 hydroxylase and 17 alpha-hydroxylase enzymes

60% are associated with Hashimoto’s thyroiditis, pernicious anemia, type 1 diabetes or idiopathic hypoparathyroidism (although patients with these common disorders only rarely develop adrenal insufficiency)

Associated with HLA-B8, DR3, DR4

45% with circulating autoantibodies but without symptoms develop impaired adrenocortical function within 2 1/2 years

Case reports: 24 year old woman with death due to pituitary and adrenal insufficiency, with heavy lymphocytic infiltration of adenohypophysis, thyroid, and adrenals, and diffuse retroperitoneal fibrosis with perivascular lymphocytic infiltrates, 2 years after delivery of normal infant (Archives 1985;109:230), due to intravascular B cell lymphoma (Hum Path 1996;27:209)

Gross: small adrenal glands with replacement by hyalinized fibrous tissue

Micro: fibrotic capsule; lymphocytes, histiocytes and plasma cells in all cortical layers; rare or small islands of remaining cortical cells with eosinophilic cytoplasm and lipid depletion; medulla is unchanged

DD: normal adrenal cortex (focal lymphocytic aggregates, but cortical cells present and no symptoms of adrenal insufficiency), chronic glucocorticoid therapy (causes atrophic adrenal glands but no inflammation, no adrenal insufficiency except in times of crisis), myelipomatous change (fat cells, lymphocytes and bone marrow elements), Carney’s complex (lymphocytes and nodules of enlarged zona reticularis-type cells, no glandular atrophy)

 

Drugs causing adrenal insufficiency

top

Aminoglutethimide: inhibits enzyme converting cholesterol to pregenolone, causes decrease in cortisol and aldosterone

Metapyrone: inhibits 11 beta hydroxylase, which inhibits cortisol and aldosterone synthesis

Mitotane: cytotoxic to zona fasciculata and reticularis, produces medical adrenalectomy; produces atrophic adrenal glands with fibrosis and residual islands of cortical cells

 

Infections

top

Cytomegalovirus (CMV): common in adrenal glands of AIDS patients, causes adrenocortical necrosis; if severe, may cause adrenal insufficiency

Echovirus: case reports at Archives 1983;107:361, Hum Path 1983;14:818

Fungi: due to Histoplasma, Cryptococcus, Paracoccidioides; enlarged glands with fibrosis, necrosis and granulomatous inflammation

Herpes simplex / varicella zoster: may involve adrenal glands, associated with extensive cortical necrosis; may cause adrenal insufficiency (Hum Path 1985;16:1091)

HIV: changes due to HIV virus itself, opportunistic infections (Mycobacterium avium-intracellulare, CMV, HSV) or associated neoplasms; may have defect in 17-deoxcorticosteroid production or peripheral resistance to glucocorticoids

Mycobacterium avium-intracellulare: sheets of histiocytes with abundant acid-fast organisms detected with acid-fast stains

 

Tuberculosis

Rare cause of adrenal insufficiency in US and Western Europe, more common elsewhere

Due to Mycobacterium tuberculosis

No symptoms until glandular destruction almost complete

Gross: adrenal glands are enlarged, yellow-gray-red and replaced by necrotic material

Micro: caseous necrosis of cortex and medulla, Langerhans’ giant cells and lymphocytes; may have thin rim of intact cortical tissue; 50% have identifiable bacteria with Ziehl-Neelsen or fluorescent stains

 

Isolated mineralocorticoid deficiency

top

Deficiency of aldosterone production by zona glomerulosa

Usually due to impaired release of renin from kidney due to diabetes mellitus, autoimmune disease, amyloidosis, sickle cell anemia; also heparin, rarely tumors or idiopathic

Primary (idiopathic) hypoaldosteronism may be due to autosomal recessive disorder associated with deficiency in CYP11B2 enzyme (converts 18-hydroxyl group to aldehyde at end of aldosterone biosynthesis); infants have failure to thrive, recurrent dehydration, salt wasting

 

Polyglandular autoimmune syndromes

top

More common in women

Type I polyglandular autoimmune syndrome: also called autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED); due to mutations in gene at 21q22.3; rare with <200 cases reported; autosomal recessive; associated with adrenal insufficiency in 60% of cases, usually by age 13 years; also chronic mucocutaneous candidiasis and hypoparathyroidism in childhood; also autoimmune thyroiditis, diabetes mellitus; variable alopecia; most have autoantibodies to glutamic acid decarboxylase

Type II polyglandular autoimmune syndrome: usually autosomal dominant; adrenal insufficiency in all cases; more common than type I; 50% familial with onset between ages 20-40 years; also autoimmune thyroiditis (Grave’s disease), insulin dependent diabetes mellitus; also primary hypogonadism, myasthenia gravis, celiac disease; only rarely hypoparathyroidism

 

Radiation

top

May cause fibrosis, although cortex is relatively radioresistant

High doses (> 5000 roentgens) to abdomen, pelvis or lumbar region may cause hyaline fibrosis of reticularis and reduction of fasciculata, although don’t necessarily affect cortical function

 

Waterhouse-Friderichsen syndrome

top

Hemorrhagic necrosis of adrenal glands, usually due to bacteremia, classically Neisseria meningitides; also Pseudomonas aeruginosa, pneumococci, staphylococcus, historically Haemophilus influenzae; less common causes are burns, cardiac failure, hypothermia, birth trauma

Symptoms are shock, disseminated intravascular coagulation and adrenal insufficiency; the shock may cause the hemorrhage

More common in children, particularly before age 2 years

Usually bilateral; newborns may have unilateral hemorrhage, more commonly in right adrenal gland

Treatment: treat underlying infection with antibiotics; also cortisol, electrolytes; must detect and treat quickly

Case reports: due to Capnocytophaga canimorsus septicemia in healthy 47 year old woman (Archives 2000;124:859), due to Echovirus type 6 in otherwise healthy newborn (Mod Path 2001;14:85)

Gross: glands are enlarged and hemorrhagic with extensive cortical and medullary necrosis

Gross images: red-brown adrenal glands due to hemorrhage

Fatal meningococcemia in 10 month old boy, courtesy Dr. Eric L. Vey, Erie County Coroner’s Officer, Erie, PA (USA)adrenal glands in situ; normal (top) and hemorrhagic (bottom) adrenal glands

Micro: hemorrhage, necrosis, fibrin deposition, neutrophilic infiltration of medulla and cortex; zona glomerulosa cells may be spared

Micro images: due to Capnocytophaga canimorsus

DD: central adrenal vein thrombosis

References: Archives 1977;101:6 (meningococcemia)

 

 

Adrenal hyperfunction/hyperplasia

Adrenal hyperfunction-general

top

Causes are Cushing’s syndrome, hyperaldosteronism, adrenogenital syndrome or other congenital adrenal hyperplasia

May be ACTH-dependent (Cushing’s disease, ectopic ACTH syndrome, ectopic CRH syndrome) or independent (hyperplasia, adenoma, carcinoma, iatrogenic)

Symptoms: initially weight gain, hypertension; later truncal obesity, moon facies, buffalo hump (fat in posterior neck and back), atrophy of fast twitch (type 2) fibers causing muscle weakness, hyperglycemia, glucosuria, polydipsia (due to increased gluconeogenesis, reduced glucose uptake by cells), loss of collagen in proteins (fragile skin), bone resorption (osteoporosis), abdominal striae, infections, mental disturbances, hirsutism, menstrual abnormalities

Diagnosis: elevated 24 hour urine free cortisol, loss of diurnal pattern of cortisol secretion

Myelolipomatous change: may be a marker of cortisol hyperactivity

 

Cushing’s syndrome

top

Excess cortisol for any reason

Causes

(a) Exogenous glucocorticoids

Most cases

(b) small ACTH-producing pituitary adenoma or hyperplasia (most common endogenous cause)

Called Cushing’s disease (Harvey Cushing observed pituitary adenomas associated with hypercortisolism in 1932)

Adrenals usually exhibit nodular or diffuse hyperplasia, have increased weight and rounded contours; outer cortical layers are yellow, inner layers tan-brown; nodules are often multiple, associated with hyperplastic cortex

Zona glomerulosa is difficult to identify in adults, fasciculata has lipid-depleted cells, reticularis cells are vacuolated

Elevated serum ACTH, cortisol and its precursors

Can suppress ACTH with high but not low dose dexamethasone

Treatment: surgical resection or radiation of pituitary tumor, surgical or medical (with mitotane) adrenalectomy

(c) bilateral adrenal hyperplasia, adrenal adenoma or adrenal carcinoma

25% of endogenous cases; also called ACTH-independent Cushing’s syndrome

80% are women

Children have more carcinomas than adenomas, produce more hypercortisolism

Adults have similar frequency of adenomas and carcinomas

Virilization: in females-male pattern baldness, clitoromegaly, deepening of voice

Feminization: in males-loss of libido, testicular atrophy, gynecomastia

Large tumors with Cushing’s syndrome or Cushing’s syndrome with obvious virilization and marked 17-ketosteroid excretion are usually carcinomas

High cortisol levels, low ACTH levels

Opposite adrenal gland is atrophic

Cannot suppress or lower ACTH with high or low dose dexamethasone

(c) Ectopic ACTH production by non-adrenal neoplasm

Tumors secrete ACTH-like substance

In adults, usually due to small cell carcinoma of lung or carcinoid tumors of lung or thymus; also medullary thyroid carcinoma, pancreatic endocrine neoplasms, pheochromocytomas, ovarian tumors

In children, tumors are usually pheochromocytoma, neuroblastoma, thymic or pancreatic endocrine neoplasms

Associated with hypokalemic alkalosis, high urinary excretion of free cortisol, skin pigmentation, edema, severe diabetes mellitus

Usually poor prognosis due to malignant disease

Treatment: resect or treat tumor, control hypercortisolism with aminoglutethimide or other drugs or bilateral adrenalectomy

Gross: enlarged adrenal glands (total 20-30g), with tan-brown, diffusely hyperplastic cortex

Micro: diffuse hyperplasia and lipid depletion of fasciculata cells; reticularis cells may exhibit atypia; often metastatic tumor also

(e) Rarely caused by tumors producing cortisol releasing factor

Usually in men, age 40-59 years

Elevated serum ACTH, cannot suppress with high or low dose dexamethasone

 

Pituitary gland changes: Crooke hyaline change-basophilic cytoplasm of ACTH producing cells changes from granular to homogenous, due to accumulation of intermediate filaments

Adrenal gland changes: exogenous cortisol causes low ACTH, which causes atrophy of fasciculata and reticularis, not glomerulosa, in residual or opposite adrenal gland

 

Hyperaldosteronism

top

Causes urinary loss of potassium and hypokalemia, sodium retention and hypertension

Diagnosis: nonsuppressible aldosterone excretion with normal cortisol excretion, low plasma renin

Primary hyperaldosteronism: due to adrenal pathology (most common are adenoma and cortical hyperplasia), idiopathic, rarely carcinoma; also called Conn’s syndrome

Secondary hyperaldosteronism: due to increased levels of plasma renin from non-adrenal pathology, including congestive heart failure, pregnancy (due to estrogen), decreased renal perfusion (renal arterial stenosis, nephrosclerosis), hypoalbuminemia, ovarian tumor, hyperthyroidism

Tertiary hyperaldosteronism (Bartter’s syndrome): hypertrophy and hyperplasia of renal juxtaglomerular cells, causing elevated plasma renin, angiotensin II and aldosterone, hypokalemic alkalosis but no hypertension; some cases are autosomal recessive; infants or adults Glucocorticoid suppressible hyperaldosteronism: rare, familial; due to mutation which causes developmental derangement of cortical zonation, with hybrid cells between glomerulosa and fasciculata that are under the influence of ACTH, but can be suppressed by dexamethasone

Symptoms: hypokalemia causes weakness, paresthesias, visual disturbances, tetany

Sodium retention causes volume overload which suppresses the renin-angiotensin system and reduces plasma renin activity; volume overload causes polyuria, polydipsia, nocturia, hypertension, alkalosis, hypernatremia

Treatment: surgery for adenoma; surgery usually not curative for bilateral adrenal hyperplasia-these patients need spironolactone or other antihypertensive drugs

Gross: adenomas are small, unilateral, solitary, golden yellow

Micro: thickened glomerulosa layer with tongue-like projections into fasciculata; spironolactone bodies in patients treated with spironolactone; variable micronodules of clear cells

Note: adenomas are usually one nodule; nodular hyperplasia is usually bilateral

 

Acquired (non-congenital) adrenocortical hyperplasia

top

Defined as non-neoplastic increase in adrenal cortical cells

Diffuse (62%) or nodular (20%) or hyperplasia with ectopic ACTH syndrome due to tumors (18%)

Diffuse cases are usually bilateral, associated with elevated ACTH produced by pituitary gland, ACTH-producing tumor or excess corticotropin-releasing factor production, rarely due to ACTH receptor autoantibodies (as with Grave’s disease)

Nodular cases usually are unrelated to ACTH production; may represent a later stage of diffuse hyperplasia in which lesion has evolved from ACTH-dependent to adrenal gland dependent

Associated with MEN1 (not neoplastic in one case, Mod Path 1999;12:919, MEN1 described below under pheochromocytoma); also thyroid neoplasms, leiomyomas, hepatic focal nodular hyperplasia, renal angiomyolipomas

Case reports: with lipomatous metaplasia (Archives 1999;123:167)

Gross: nodular variant - at least one nodule 0.5 cm in diameter, often diffusely nodular adrenal cortex, weighs 6 grams or more without fat; glands have rounded edges

Gross images: bilateral cortical hyperplasia (bottom);  nodular with variegated surface due to lipomatous metaplasia

Micro: increased thickness of zona reticularis and fasciculata; cells in fasciculata may appear lipid depleted; atypical cells with large hyperchromatic nuclei may be present in nodules (“endocrine atypia”); small micronodules may be present near central vein, containing lipid-laden clear cells similar to zona fasciculata

Micro images: diffuse hyperplasia of adrenocortical cells; lipomatous metaplasia

Molecular: cells may be aneuploid or polyploid

EM: abundant smooth endoplasmic reticulum, long microvilli

DD: adenoma (single nodule, clonal)

 

Macronodular hyperplasia

top

Large (0.5 cm or more), bilateral nodules of histologically unremarkable adrenocortical tissue in adrenal cortex or protruding into adjacent adipose tissue

Rare (<100 cases reported)

Mean age 45-55 years

Laboratory: elevated plasma cortisol not suppressed by dexamethasone, low serum ACTH

Treatment: bilateral adrenalectomy, does not appear to recur

Gross: enlarged adrenal glands, up to 200g; may be “massive”; nodules from 0.2 to 4.0 cm, yellow-tan, not encapsulated

Micro: nodules composed of clear cells and compact cells with variable lipid; variable myelolipomatous change, osseous metaplasia or atrophic cortex between nodules; no/rare mitotic figures or atypia

DD: ACTH dependent hyperplasia due to pituitary disease

 

Micronodular hyperplasia

top

Small (less than 0.5 cm) nodules of histologically unremarkable adrenocortical tissue in adrenal cortex or protruding into adjacent adipose tissue

Often multiple and bilateral; microscopic or grossly visible

Associated with older age, hypertension, diabetes

At autopsy, present in 3% of all ages, 20% with hypertension, 29% of women with mean age 81 years

May represent localized overgrowth of adrenocortical cells

Usually nonfunctional; no clinical significance

Gross: unencapsulated, may protrude into capsule, may completely detach from capsule

Micro: cortical cells may stream into periadrenal fat; adrenal arteries often are hyalinized with intimal proliferation that causes luminal obliteration; may have neuromelanin pigment; may undergo myelolipomatous or osseous metaplasia

Virtual slides: micronodular hyperplasia

DD: adenoma (usually solitary, circumscribed), carcinoma (mitotic activity, atypical mitotic figures, necrosis)

 

Pigmented adrenal cortical hyperplasia

top

Also called primary pigmented nodular adrenocortical disease

Rare cause of ACTH-independent Cushing’s syndrome (Mod Path 1992;5:23)

May be familial, autosomal dominant, and associated with Carney’s complex [cutaneous abnormalities in 80% (lentigenes, blue nevi, ephelides, myxomas), cardiac myxomas (72%, may be life threatening), large cell calcifying Sertoli tumors and Leydig cell tumors of testis (56%), primary pigmented nodular adrenocortical disease with Cushing’s syndrome (32-45%), myxoid fibroadenomas of breast in females (42%), growth hormone secreting pituitary adenomas (10%), uterine myxomas (8%), oral cavity myxomas (8%), psammomatous melanotic schwannomas (5%); also neurofibromatosis, cerebral hemangioma]; associated with 2p16 abnormalities

Note: Carney’s complex is also called LAMB syndrome (Lentigenes, Atrial myxomas, Mucocutaneous myxomas, Blue nevi), NAME syndrome (Nevi, Atrial Myxomas, Myxoid neurofibroma, Ephelides) or Swiss syndrome

Sporadic and nonfamilial patients are usually infants or age < 30 years

Laboratory: moderately elevated plasma cortisol but no diurnal rhythm, resistant to dexamethasone suppression, low/undetectable plasma ACTH

Treatment: bilateral adrenalectomy

Gross: variably sized adrenal glands with multiple brown-black pigmented cortical nodules, 1 mm to 3 cm, and atrophy of adjacent cortical tissue; nodules may extend into corticomedullary junction or periadrenal fat

Micro: sharply circumscribed but unencapsulated nodules composed of large, eosinophilic, lipid-poor cells similar to zona reticularis, but often with enlarged pleomorphic nuclei , prominent nucleoli and prominent lipofuscin deposits; also lipid-rich fasciculata-like cells; may have focal necrosis, mitotic activity, trabecular growth pattern, myelolipomatous change, lymphocytic infiltrates

EM: zona reticularis and fasciculata type cells; abundant lipofuscin type bodies

DD: melanoma

References: AJSP 1989;13:921; AJSP 1984;8:335

 

Unilateral adrenocortical hyperplasia

top

Rare

May represent bilateral disease with only a few microscopic nodules in the other gland

Cases with low plasma ACTH may represent unilateral adenomas

 

 

Adrenocortical adenoma

Adrenocortical adenoma-children

top

Rare, 25 cases annually in US

Usually hormone-related symptoms with virilization, Cushing’s syndrome, mixed endocrine syndromes; rarely feminization or Conn’s syndrome

75% of adrenocortical neoplasms in children are carcinomas, although only 31% of histologically malignant tumors had clinically malignant behavior

Malignant behavior associated with vena cava invasion, tumor necrosis, >15 mitotic figures/20 HPF, although cannot rely on a single histological feature

Proposed criteria for malignancy in children: > 400g, > 10.5 cm, extension into adjacent soft tissue/organs, extension into vena cava, capsular invasion, vascular invasion, tumor necrosis, > 15 mitotic figures/20 HPF, atypical mitotic figures

Gross: mean 9 cm, range 2-20 cm

Positive stains: inhibin, vimentin, CK5, p53 (focal), Ki-67 (focal)

References: AJSP 2003;27:867

 

Adrenocortical adenoma-general

top

2/3 women, usually ages 30-40 years

Detected incidentally at autopsy (usually nonfunctional), from unrelated radiographic studies, or due to hyperfunction of zona glomerulosa (increased mineralocorticoids / Conn’s syndrome), zona fasciculata (increased glucocorticoids / Cushing’s syndrome) or zona reticularis (increased sex steroids / adrenogenital syndrome)

If nonfunctional, adjacent adrenal has normal cortical thickness; if functional, adjacent adrenal will be atrophic

May be ectopic (i.e. not located in adrenal gland)

Rarely mixed together with pheochromocytoma or myelolipoma

Diagnose as “adrenocortical neoplasm” and estimate risk of recurrent or metastatic tumor if cannot differentiate between adenoma and carcinoma

Somewhat common site for lung metastases, for unknown reasons (Archives 1988;112:286)

Treatment: excision

Case reports: with massive hemorrhage and thrombosis, resembling angiosarcoma (AJSP 1991;15:699), with clinical features of pheochromocytoma and adrenal-type granules on EM (Archives 2002;126:1530), with APC gene mutation (Hum Path 1998;29:302), ectopic tumor in spinal intradural space of 8 year old girl (AJSP 1990;14:481), with compound pheochromocytoma and ganglioneuroma in same adrenal gland (AJSP 1988;12:559)

Gross: usually < 2 cm and < 50g; encapsulated, well circumscribed, solitary; solid, homogenous yellow cut surface; usually no hemorrhage or necrosis

Gross images: well circumscribed tumor

Micro: resemble zona fasciculata cells more than glomerulosa cells due to numerous lipid-laden clear cells; endocrine atypia (bizarre nuclear forms) may occur; may appear pigmented due to lipofuscin or neuromelanin (“black adenoma”); mitotic figures rare/absent; rarely has cells with medullary differentiation, oncocytes (see oncocytoma), adipose tissue

Micro images: (1) tumor cells resemble zona fasciculata; (2) compact cells arranged in nests #1; #2; (4) multinucleated cells; (5) focal atypia #1; #2; (7) figure 2A: cells have vacuolated cytoplasm; (8) melanA/A103: figure 1: adenoma is +; figure 2: pheochromocytoma is negative

Virtual slides: adenoma

Positive stains: low molecular weight keratin (usually), MelanA/MART1 (Archives 2002;126:170, AJSP 1998;22:57; AJSP 1998;22:595), synaptophysin, inhibin (Mod Path 1998;11:1160), bcl2 (Mod Path 1998;11:716), calretinin (focal, Hum Path 2003;34:994)

Negative stains: EMA, CEA, B72.3, S100, chromogranin, vimentin (usually)

Molecular: 20% aneuploid (so ploidy does not predict malignancy)

EM: tubulovesicular mitochondria, lipid vacuoles, smooth endoplasmic reticulum.

DD: adrenal cortical carcinomas (usually larger, more variegated with hemorrhage or necrosis, venous invasion, atypia and mitotic activity; see also Weiss criteria for malignancy under carcinoma); pheochromocytoma with lipid degeneration (AJSP 1987;11:480)

 

Adenomas associated with adrenogenital syndrome

top

Feminization or pure adrenogenital syndrome strongly suggests carcinoma, not adenoma

Virilizing adenomas may be up to 500 g

Gross: sharply circumscribed or encapsulated, red-brown

Micro: large tumors have solid/diffuse patterns; smaller tumors have alveolar growth; cytoplasm is granular and eosinophilic; most cells have bland nuclear features, but occasional cells with nuclear enlargement and pleomorphism are present

EM: mitochondria have tubulolamellar cristae

 

Adenomas associated with Cushing’s syndrome

top

Case reports: 2 women with bilateral adrenocortical adenomas causing Cushing’s syndrome (Archives 1992;116:146)

Gross: usually unilateral, sharply circumscribed or encapsulated, 3-4 cm, < 60g (suspicious for malignancy if > 100g), yellow-brown, occasionally black, often cystic change, usually no necrosis

Gross images: well circumscribed adenoma

Micro: small nests, cords or alveolar patterns of enlarged, vacuolated clear cells resembling fasciculata; may have compact-type cells; lipochrome rich compact cells are prominent in black adenomas; variable fibrosis; occasional enlarged hyperchromatic nuclei, but most are vesicular with small nucleoli; large tumors may have myelolipomatous foci or calcification; no/rare mitotic figures; adjacent cortex has atrophy of fasciculata and reticularis layers, but not glomerulosa

Cytology: round to polyhedral cells with foamy cytoplasm, round nuclei; also naked nuclei in background of granular and foamy material

Molecular: variable clonality

EM: resemble normal fasciculata or reticularis; abundant smooth endoplasmic reticulum, round/ovoid mitochondria with usually tubulovesicular or vesicular cristae; variable lipid droplets

 

Adenomas associated with hyperaldosteronism (Conn’s syndrome)

top

Usually also secrete other steroid hormones

Usually women in 30’s to 40’s with hypokalemia, normal serum sodium, elevated plasma or urine aldosterone

Rare but curable cause of hypertension

Case reports: 54 year old, 112 kg man with myeloma and difficult to control hypertension (Archives 2003;127:883), 57 year old man with hypertension, chronic hypokalemia, adenoma and renal cell carcinoma (Archives 2003;127:495), black (pigmented) adenoma (Archives 1991;115:813)

Treatment: resection with spironolactone pretreatment, may recur

Gross: usually unilateral and solitary, often < 6 grams or < 2 cm; cut surface is golden-yellow to yellow-brown, sharply demarcated by pseudocapsule; rarely is “black adenoma”; adjacent adrenal cortex is non-atrophic

Gross images: tan-yellow tumor, 1.3 cm

Micro: small nests and cords of fasciculata-like or glomerulosa-fasciculata cells; spironolactone bodies present (whorled, concentric, multilaminar collection of eosinophilic membranes, up to 20 microns, aldosterone+, in patients treated with spironolactone); some atypical cells with nuclear pleomorphism; no/rare mitotic figures

Micro images: (1) figure 1: nesting pattern separated by fine microvasculature; 2: numerous spironolactone bodies; (2) figure 1: spironolactone bodies; 2: Luxol fast blue+; 3: renal clear cell carcinoma

Positive stains: spironolactone bodies–PAS+ diastase resistant, Luxol fast blue

EM: lamellar cristae and some tubulovesicular cristae; spironolactone bodies resemble myelin figures

 

Myxoid

top

Rare

No recurrence or metastases

Myxoid foci positive with Alcian blue, negative with PAS, mucicarmine

Otherwise similar staining to ordinary adenomas

References: AJSP 2000;24:396

 

Nonfunctioning adenomas / nodules

top

Present in 25% at autopsy; also commonly detected by CT and MRI

Pigmented nodules in up to 1/3 of normal adults

Associated with elderly, diabetes mellitus, idiopathic hypertension, aldosterone-secreting adenomas

Case reports: incidental pigmented nodule with cytomegaly (Archives 1985;109:198)

Gross: multicentric, bilateral, up to 3 cm; fibrous capsule for larger nodules; yellow with brown discoloration; adjacent cortex is not atrophic

Micro: fasciculata type cells, occasional myelolipomatous change or ossification

 

Oncocytoma

top

Tumor cells packed with mitochondria with tubulovesicular cristae typical of steroid-producing cells

Rare; usually nonfunctioning, usually benign

Mean age 45 years, range 27-74 years

Confirm adrenocortical origin by immunoreactivity to 3-beta-hydroxysteroid dehydrogenase, the enzyme that converts pregnenolone to progesterone and dehydroepiandrosterone to androstenedione

Clinical behavior not entirely predictable; Weiss system for malignancy not applicable because all tumors have eosinophilic tumor cytoplasm, diffuse architecture and nuclear atypia; better to use criteria of mitotic activity, necrosis, invasion, MIB1 activity

Case reports: 55 year old woman with 13 cm tumor (Archives 2003;127:e167), retroperitoneal oncocytoma of apparent adrenocortical origin (Archives 2002;126:1118)

Gross: light to dark brown, solid, well circumscribed, up to 20 cm

Gross/Xray images (ectopic tumor): solid tumor with smooth external surface

Micro: alveolar, tubular or solid patterns composed exclusively of oncocytes (epithelial cells with abundant eosinophilic, granular cytoplasm and sparse lipid), nuclear atypia common; no/rare mitotic activity, no necrosis

Tumors of uncertain malignant potential: increased mitotic activity and necrosis, but no invasion

Micro images: (1) figure 1: solid tan-brown mass with variegated cut surface; 2: sheets of large polygonal cells with abundant eosinophilic granular cytoplasm and small central nucleus; 3: EM shows dense mitochondria with platelike cristae, scattered non-membrane bound electron-dense granules;  (2) a: nests of cells with abundant, eosinophilic granular cytoplasm; b: PTAH+;  (3) 3 beta-hydroxysteroid dehydrogenase immunohistology

Positive stains: keratin (CAM 5.2, AE3), anti-mitochondrial antibody, PTAH, NSE, synaptophysin, low MIB1 (except in tumors of uncertain malignant potential), variable vimentin

Negative stains: chromogranin A, EMA, S100, p53

EM: numerous mitochondria, with stacked tubulo-vesicular and lamellar cristae, smooth endoplasmic reticulum, lysosomes, small electron dense inclusions

DD: oncocytic carcinoma, oncocytic pheochromocytoma (chromogranin A+), adrenocortical tumors with focal oncocytic change, eosinophilic variants of renal cell carcinoma (EMA+, NSE-, synaptophysin-)

References: AJSP 1998;22:603; AJSP 1991;15:949 (3 cases)

 

Corticomedullary mixed tumor

top

Rare, <20 cases reported

Single mass of admixed population of adrenal cortical and medullary cells

By definition, excludes simultaneously occurring adrenocortical adenomas and pheochromocytomas, ACTH-producing pheochromocytomas with associated adrenocortical hyperplasia

May be a collision tumor

85% women, mean age 50 years, range 32-61 years

Usually present with Cushing’s syndrome that resolves after tumor excision

Benign behavior

Case reports: 55 year old woman with Cushing’s syndrome and incidental myelolipoma (Archives 2003;127:e329)

Gross images: figure 1: well circumscribed, tan-yellow tumor; normal adrenal gland at bottom; 2: H&E of classic myelolipoma with hematopoietic cells and fat cells, and normal adrenocortical tissue at bottom; 3A: EM shows cytoplasmic granules of adrenal medullary origin (upper left) and lipid droplets of adrenal cortical origin (lower right); 3B: EM shows cytoplasmic dense-core granules of adrenal medullary origin

Micro: mixture of medullary pheochromocytoma cells (abundant, finely granular eosinophilic cytoplasm and round/oval nuclei with coarse chromatin) and adrenocortical tumor cells (clear cytoplasm)

Micro images: (1) mixture of adrenocortical cells and pheochromocytoma cells; (2) pheochromocytoma component with abundant, finely granular cytoplasm and round/oval nuclei; (3) adrenocortical adenoma component with clear cytoplasm; (4) tumor thrombosis and recanalization of vascular channels #1; #2; (6) pheochromocytoma cells are chromogranin+; (7) synaptophysin+; (8) neuron specific enolase+; (9) sustentacular cells are S100+; (10) A: sheets, nests and cords of polygonal cells with clear cytoplasm; B: adrenocortical cells have clear vacuolated cytoplasm and small dark nuclei; adrenal medullary cells have granular basophilic cytoplasm and variably sized nuclei; C/D: calretinin+ (brown) adrenocortical cells and chromogranin+ (blue) pheochromocytes of adrenal medullary origin

 

 

Other benign cortical lesions

Adenomatoid tumor of adrenal gland

top

Very rare; tumors often incidental

Mean age 41 years, range 31-64 years, 90% male

Benign; resembles adenomatoid tumors of genital tract

Case reports: 33 year old man with 2 cm tumor (Archives 2003;127:1633), tumor with prominent cystic component (Archives 1990;114:722), patient with hypertension and clinical impression of pheochromocytoma (Archives 1990;114:725), 51 year old man with tumor and micronodular adrenal cortical hyperplasia (Hum Path 2003;34:818)

Gross: 1-4 cm, originates within adrenal gland, well-circumscribed, white-tan-gray, may have cystic structures

Micro: adenoid, angiomatoid, cystic and solid patterns of anastomosing glands and tubules of variable size lined by epithelioid and flattened cells; cells have low nuclear/cytoplasmic ratio, no mitotic activity; involves adrenal cortex, often medulla and often extends into adjacent adipose tissue with signet-ring like cells

Micro images: figure A: CT shows small adrenal gland mass; B: tumor composed of variably sized cystic spaces, focally infiltrative into adrenal tissue; C: calretinin+; D: EM shows numerous long, bushy microvilli on luminal surfaces, desmosomes (arrows), cytoplasmic fibrillar networks

Positive stains: calretinin, AE1/AE3, CAM 5.2, CK7, vimentin, CK5/6 (weak)

Negative stains: CK20, CD15, CD31, CD34, MOC31, CEA, MIB1 (low activity)

Molecular: diploid or tetraploid

EM: well formed desmosomes, extensively developed microvilli

DD: hemangioma, angiosarcoma, lymphangioma, malignant mesothelioma, yolk sac tumor, metastatic adenocarcinoma (including signet-ring cell), adrenal cyst

References: AJSP 2003;27:969; Mod Path 1996;9:1046

 

Cysts

top

May produce mass or flank pain, or incidental finding on MRI or CT scans

Incidence of 0.06% at autopsy

Usually women

Case reports: 61 year old woman with incidental cyst containing ectopic thyroid tissue (Case of Week #188)

Treatment: excision

Gross: up to 30 cm, usually unilateral with irregular thick fibrous wall and calcifications; often yellow, residual adrenocortical tissue in wall

DD: cystic degeneration of adrenocortical neoplasm

References: Archives 1985;109:377

 

Bronchogenic cyst in retroperitoneum

top

Case report at Archives 1991;115:1057

 

Endothelial (vascular) cyst

top

See also hemorrhagic cyst below

45% of adrenal cysts

8% bilateral, 2/3 female

Gross: up to 50 cm, multiloculated with serous fluid

Gross images: 36 cm cyst #1; #2; #3

Micro: endothelial lining, may have residual adrenocortical tissue in wall

Micro images: (1) wall of hyalinized fibrous tissue #1; #2; (3) elastic stain shows elastic tissue within wall; (4) focal lining of flattened endothelial cells determines diagnosis of endothelial cyst; (5) organizing clot; (6) nests of trapped adrenocortical tissue; (7) vascular channels within fibrous wall

Positive stains: collagen type IV+, weak staining for factor VIII related antigen

 

Epithelial lined (true) cyst

top

Rare

May be derived from mesothelial structures

Either retention cysts, embryonal cysts or arising within adrenocortical adenomas (Hum Path 1989;20:491)

Micro: single layer of keratin+ cells

 

Hemorrhagic cyst (pseudocyst)

top

39% of adrenal cysts

Usually women, median age 41 years

May be associated with Beckwith-Wiedemann syndrome

Actually an endothelial (vascular) cyst or perhaps lymphangioendothelial cyst with subsequent hemorrhage, fibrosis and hemosiderin deposition; enlargement is due to hemorrhage and fluid accumulation

Gross: 2-10 cm or large

Micro: hyalinized fibrous capsule containing clotted blood, residual adrenocortical tissue and thin walled vascular channels in wall but no identifiable cyst lining

Positive stains: collagen type IV (strong), factor VIII related antigen, CD34, laminin

References: Archives 1986;110:121; Hum Path 1989;20:660; Mod Path 1997;10:530; AJSP 1989;13:740 (endothelial cysts and pseudocyts)

 

Lymphangioma

top

Rare (0.06% incidence)

Case report of 22 year old woman with 4 cm mass (Archives 2004;128:713)

Micro: thin walled cyst with smooth lining and flattened endothelial cells (CD31+)

Micro images: figure 1: MRI shows cystic suprarenal mass; 2: irregular cystic spaces lined by flattened endothelial cells, with adjacent normal adrenal cortex; 3: CD31+

 

Parasitic cyst

top

Usually echinococcal, often incidental

80% are pseudocysts, also endothelial cysts (17.5%) or epithelial cysts (2.5%)

Case reports: visceral leishmaniasis (Archives 2000;124:1553)

Micro: wall contains many eosinophils, also evidence of parasite

Micro images: visceral leishmaniasis - 1A: large cystic mass by CT scan; 1B: large adrenal gland mass compressing kidney; 2A: adrenal mass is semicystic with hemorrhage and necrosis; 2B: clotted blood and thin-walled endothelial channels; 3A/B: cyst wall has Leishmania amastigotes within macrophages and giant cells

DD: degeneration of adrenal neoplasm (grossly)

References: Hum Path 2000;31:75

 

Focal adrenalitis

top

Present in half of autopsied patients

Associated with chronic pyelonephritis

Micro: focal lymphoplasmacytic infiltrate in adrenal cortex

DD: Addison’s disease

 

Hemangioma

top

Usually cavernous, detected incidentally at autopsy

Solitary

DD: adrenal cortical adenoma with degeneration and secondary vascular changes

 

Malakoplakia

top

Case reports: 6 week old infant involving adrenal gland and colon (Archives 1975;99:198); adult woman with E. coli infection (J Clin Path 1981;34:606)

 

Massive macronodular adrenal cortical disease

top

ACTH independent, may involve only a single gland

Bimodal age distribution: newborns (associated with McCune-Albright syndrome) and age 40+; rarely familial

Gross: glands up to 180g together, nodules up to 4 cm, non-nodular cortex may be atrophic

Micro: clear cells or compact cells

DD: neoplasm

 

Myelolipoma

top

Rare, benign, usually solitary tumor composed of hematopoietic precursor cells and mature fat

Usually an incidental autopsy finding (0.1 to 0.2% of cases) or incidental CT / MRI finding

Not associated with hematologic disorders; nonfunctioning

Most patients are obese adults (mean age 50 years)

May have areas of fibromyxoid degeneration resembling low-grade fibromyxoid sarcomas

Focal myelolipomatous change also in adrenocortical hyperplasia and tumors; usually incidental (Archives 1994;118:895)

May be metaplastic change in reticuloendothelial cells of blood capillaries in response to necrosis, infection or stress

Treatment: follow up or excision if symptomatic

Case reports: 70 year old woman with 52 year history of abdominal mass and 5 kg tumor (Archives 1981;105:532), 66 year old woman with 8 cm tumor (Archives 2004;128:703), bilateral giant tumors (Archives 1995;119:283), patient with congenital adrenal hyperplasia and giant adrenal tumor (AJSP 1979;3:109), association with 17-hydroxylase deficiency (Archives 1985;109:1116), myelolipoma and ganglioneuroma of adrenal medulla (Archives 2002;126:736), with subclinical Cushing’s disease (Archives 1997;121:735), arising in spleen (Archives 1995;119:561), giant extra-adrenal tumor (Archives 1994;118:188)

Gross: nonencapsulated, bright yellow adipose-like tissue with hemorrhagic foci (contains marrow tissue); may be up to 5 kg

Gross images: 24 cm tumor #1; #2

Micro: mature islands of hematopoietic cells and mature fat; larger tumors may have hemorrhage, necrosis, calcification, cyst formation

Micro images: (1) classic tumor #1; #2; (3) mature adipose and hematopoietic cells-various images; (4) with ganglioneuroma

DD: myelolipomatous change in cortical adenomas or cortical hyperplasia; also liposarcoma, myxoid malignant fibrous histiocytoma, extramedullary hematopoietic tumors, angiomyolipoma, teratoma

 

Ovarian thecal metaplasia

top

Also called stromal spindle nodules

Present in 5% of women (usually postmenopausal) undergoing adrenalectomy for metastatic breast carcinoma, rare in men

May be due to metaplasia from adrenal capsule mesenchymal cells due to unopposed pituitary gonadotropin during menopause

Usually no clinical significance

Case reports: virilizing Leydig cell adenoma in oophorectomized postmenopausal woman (AJSP 1986;10:816), 59 year old woman with virilizing ganglioneuroma (AJSP 1983;7:699), 49 year old woman with ovarian thecal metaplasia in adrenal gland, adrenocortical adenoma and pancreatic tissue with nesidiodysplasia (Archives 2004;128:1294), incidental finding at autopsy in 77 year old man with acquired bilateral testicular atrophy, probably due to prior bilateral inguinal herniorrhaphy (Archives 1989;113:1071)

Gross: multiple, bilateral nodules in adrenal cortex, grossly visible (up to 2 cm) or microscopic

Micro: proliferation of spindle cells in capsule, surrounding small nests of cortical cells

Micro images: figure 1: pancreatic ductuloinsular complexes; 2A: somatostatin+; 2B: pancreatic polypeptide+; 3: adrenal gland with nodules composed of nests of oval/spindle cells with bland nuclei, surrounded by eosinophilic hyalinized stroma; inset-cells are progesterone receptor+; 4: adrenal gland lesion has individual cells surrounded by reticulin fibers; arrows-reticulin surrounds nests, not individual cells, of entrapped normal cortical cells

 

Solitary fibrous tumor

top

Very rare

Case reports: 42 year old woman with incidental tumor (Mod Path 1996;9:1170)

Micro: unencapsulated tumor of small, round, epithelioid cells; mostly hemorrhagic in case above

Positive stains: CD34 (weak)

 

 

Adrenocortical carcinoma

Adrenocortical carcinoma-general

top

Rare, 0.5-2 cases per million annually in US

No gender preference, mean age 50 years, small peak before age 20 years

Associated with Li Fraumeni syndrome, Beckwith-Wiedemann syndrome, congenital adrenal hyperplasia

50% are functional and associated with virilizing and other syndromes; cannot determine function from morphology

Lack of function may be due to deletions in enzymes required for cortisol synthesis

Highly necrotic tumors may cause fever and simulate an infectious process clinically

Tend to invade adrenal vein, vena cava, adjacent kidney, retroperitoneum; may cause thromboemboli

Metastases to liver (60%), regional lymph nodes (40%), lungs (40%), peritoneal and pleural surfaces, bone, skin (anaplastic tumors), retroperitoneum

Only definitive criteria for malignancy are distant metastasis or local invasion

Often cannot differentiate between adenoma and carcinoma-call adrenocortical neoplasm and estimate risk of recurrent or metastatic tumor

In children, malignant appearing tumors often have good prognosis, particularly if < 5 years old at diagnosis, complete resection, tumor < 400g, < 15 mitotic figures/20 HPF, minimal tumor necrosis

Poor prognostic factors: mitotic activity, venous invasion, weight of 50g+; diameter of 6.5 cm+, Ki-67/MIB1 labeling index of 4%+, p53+

 

Original Weiss criteria for malignancy (AJSP 1984;8:163), modified as indicated below, require 3 or more of these factors:

(1) nuclear grade III or IV based on criteria of Fuhrman

(2) > 5 mitotic figures/50 HPF (40x objective), counting 10 random fields in area of greatest number of mitotic figures on 5 slides with greatest number of mitoses

(3) presence of atypical mitotic figures (abnormal distribution of chromosomes or excessive number of mitotic spindles)

(4) clear or vacuolated cells comprising 25% or less of tumor

(5) diffuse architecture (more than 1/3 of tumor forms patternless sheets of cells; trabecular, cord, columnar, alveolar or nesting is not considered to be diffuse

(6) microscopic necrosis

(7) venous invasion (veins must have smooth muscle in wall; tumor cell clusters or sheets forming polypoid projections into vessel lumen or polypoid tumor thrombi covered by endothelial layer)

(8) sinusoidal invasion (sinusoid is endothelial lined vessel in adrenal gland with little supportive tissue; consider only sinusoids within tumor)

(9) capsular invasion (nests or cords of tumor extending into or through the capsule with a stromal reaction); either incomplete or complete

Note: above criteria may not apply to childhood tumors

 

Modified Weiss criteria (using 1 if above factor is present in tumor, 0 otherwise):

2x mitotic rate score + 2x clear cytoplasm score + abnormal mitoses + necrosis + capsular invasion (score of 3 or more suggests malignancy, AJSP 2002;26:1612)

 

Malignant cases compared to adenomas usually show loss of heterozygosity (61%) at some loci; retinoblastoma gene (80%), p53 (44%), 9p (26%), 1p (22%), 3p (22%); more likely to be aneuploid or tetraploid (Hum Path 1998;29:518); spindling of tumor cells also suggests malignancy

2 year survival is 50%, 5 year survival is 20-35%

Treatment: surgical excision; excision of solitary lung metastases

Case reports: coexistent choroid plexus carcinoma in 18 month boy with no family history, both tumors p53+ (Archives 2002;126:70), tumor in MSH2 carrier, but without MSH2 mutation in adrenal tumor (Hum Path 2000;31:1522), small histologically benign tumor (40g) that metastasized after excision (Archives 1986;110:1076)

Gross: unencapsulated; large (200 grams, 20 cm); variegated cut surface due to hemorrhage, cysts, necrosis; often has soft, friable intratumoral nodules; often invasion of major veins

Gross images: (1) large tumor dwarfing kidney; (2) large tumor displacing kidney and spleen; (3) 250g, 10 cm tumor; (4) large tumor compressing kidney #1; #2; #3; (7) large tumor with hemorrhage #1; #2

Micro: various growth patterns; well differentiated to anaplastic cells (giant cells with bizarre hyperchromatic nuclei); capsular invasion, marked mitotic activity with atypical forms; may have neutrophils, tumor giant cells, sarcomatoid features, eosinophilic globular inclusions, necrosis

Cytology: single cells, poorly cohesive cell clusters in necrotic background, often but not always marked nuclear atypia and mitotic activity; cytoplasm is vacuolated to densely eosinophilic

Micro images: (1) polygonal cells with vascular stroma and focal necrosis; (2) tumor cells have abundant eosinophilic cytoplasm, mildly pleomorphic and vesicular nuclei, prominent nucleoli; (3) capsular infiltration; (4) tumor with mitotic figure (arrow); (5) adrenal vein invasion; (6) synaptophysin+; (7) various micro images and stains; (8) A: polygonal cells with abundant eosinophilic and microvacuolar cytoplasm, round and bizarre nuclei; B: p53+; C: p53+ normal appearing adrenal cortex (curved arrows); medulla was p53- (straight arrows); D: EM shows tubular cristae (solid arrows) and cytoplasmic fat (open arrows)

Micro images: A: H&E; B: calretinin+; C: MelanA+; D: inhibin negative

Virtual slides: adrenocortical carcinoma

Positive stains: vimentin, MelanA/MART1 (Archives 2002;126:170, AJSP 1998;22:57), synaptophysin, inhibin (usually, Mod Path 1998;11:1160), bcl2 (Mod Path 1998;11:716), adrenal 4 binding protein (regulates expression of steroid enzymes, Hum Path 1995;26:1154), p53; variable synaptophysin, neurofilament, neuron specific enolase, calretinin, HepPar1, S100 and CAM 5.2

Negative stains: CK7, CK20, EMA, CEA, B72.3, chromogranin

Molecular: usually aneuploid (69%), but ploidy is not helpful in determining behavior

EM: tubular cristae in mitochondria and droplets of cytoplasmic fat; occasionally dense core granules (associated with neuroendocrine immunostains)

EM images: figure 3D

DD: adrenal cortical adenoma (see Weiss criteria above), renal cell carcinoma (usually contains glands which may contain red blood cells, glycogen+, keratin+, EMA+, CD10+, MelanA-, synaptophysin-, inhibin-), adrenal medullary tumors (inhibin-, MelanA-, calretinin-, chromogranin+), hepatocellular carcinoma

References: AJSP 1997;21:556 (MIB1 and p53 as prognostic markers)

 

Adenosquamous adrenocortical carcinoma

top

Case report at Archives 1995;119:260

DD: metastases

 

Carcinosarcoma

top

Has sarcoma-like elements

Case reports: with osteoid differentiation and hyperaldosteronism (AJSP 1993;17:941), 29 year old woman with virilization (AJSP 1992;16:626)

 

Clear cell carcinoma

top

Negative for albumin ISH, which differentiates adrenal tumors metastatic to liver from liver primaries (AJSP 2000;24:177)

 

Myxoid carcinoma

top

Rare, <20 cases reported

Presence of myxoid change does not appear to influence tumor behavior

Case reports: myxoid change and extensive lipomatous metaplasia (Archives 2003;127:227), 41 year old woman with coexisting parathyroid hyperplasia and pituitary tumor (Archives 1979;103:635), Archives 1994;118:1151

Micro: atypical round cells with eosinophilic to vacuolated cytoplasm, stroma with copious mucinous material

Positive stains: Alcian blue; usual stains for adrenocortical carcinoma

Negative stains: PAS, mucicarmine

References: AJSP 2000;24:396

 

Oncocytic carcinoma

top

Rare, <50 cases reported

Ages 39-71

Usually non-functional

One tumor invaded the inferior vena cava and extended into the right atrium, another metastasized to bone

Weiss system for malignancy not applicable because all tumors have eosinophilic tumor cytoplasm, diffuse architecture and nuclear atypia; better to use criteria of mitotic activity, necrosis, invasion, MIB1 activity

Gross: large yellow-tan tumors (8.5 to 17.0 cm), well demarcated from adjacent kidney; thin rim of normal adrenal gland

Gross image: large multinodular yellow tumor with central necrosis

Micro: diffuse proliferation of polygonal cells with abundant granular and eosinophilic cytoplasm, large nuclei, prominent nucleoli; occasional mononuclear and binucleated giant cells; often extracapsular extension, blood vessel invasion and necrosis; variable atypia; rare mitotic figures

Micro images: (1) large, polygonal, eosinophilic tumor cells; (2) cords of tumor cells separated by dilated sinusoids; (3) cells have abundant eosinophilic cytoplasm and prominent nucleoli; (4) aggregates of foamy cells; (5) AE1/AE3+; (6) inhibin+

Positive stains: AE1-AE3, CAM5.2, inhibin (1 of 4 tumors)

EM: numerous mitochondria

EM images: prominent nucleoli, perinuclear rough endoplasmic reticulum, mitochondria, lipid droplets

DD:

(a) adrenocortical oncocytoma (well circumscribed, no capsular extension, no vascular invasion),

(b) conventional adrenocortical carcinoma,

(c) pheochromocytoma (episodic hypertension, zellballen pattern, chromogranin+, S100+ in sustentacular cells, abundant dense-core membrane-bound granules on EM),

(d) eosinophilic variant of chromophobe renal cell carcinoma (EMA+, microvesicles by EM),

(e) metastatic hepatocellular carcinoma (Hepar-1 positive)

References: Mod Path 2002;15:973

 

Staging of Adrenocortical carcinoma

top

 

Staging system proposed by MacFarlane, modified by Sullivan and Henley

top

 

Stage 1: Confined to gland, 5 cm or less

Stage 2: Confined to gland, more than 5 cm

Stage 3: Extends outside gland without involving adjacent organs, any size

Stage 4: Distant metastasis or involvement of adjacent organs

 

TNM Staging system from AJCC, 7th edition

top

 

Note: TNM and stage grouping are for adrenal cortical carcinoma only, and were created for first time in AJCC 7th edition

Classification is not intended for adrenal medullary tumors, adenoma or neuroblastoma

 

Primary tumor (T)

 

TX: Primary tumor cannot be assessed

T0: No evidence of primary tumor

T1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion

T2: Tumor greater than 5 cm, no extra-adrenal invasion

T3: Tumor of any size with local invasion, but not invading adjacent organs*

T4: Tumor of any size with invasion of adjacent organs*

 

* Adjacent organs are kidney, diaphragm, great vessels, pancreas, spleen and liver

 

Regional lymph nodes (N)

Note: regional lymph nodes are aortic (para- and peri-aortic) and retroperitoneal NOS

 

NX: Regional lymph nodes cannot be assessed

N0: No regional lymph node metastasis

N1: Metastasis in regional lymph node(s)

 

Distant metastasis (M)

 

M0: No distant metastasis

M1: Distant metastasis

 

Stage grouping

top

 

I - T1 N0 M0

II - T2 N0 M0

III - T1-T2 N1 M0 or T3 N0 M0

IV - M1 or T4 or T3 N1 M0

 

Features to report-Adrenocortical carcinoma

top

Tumor size and weight

Tumor location

Histologic type

Invasion of adjacent tissue

Margin involvement

Angiolymphatic invasion

Sinusoidal invasion

Capsular invasion

Presence of tumor necrosis, hyperplasia, adenoma, nuclear grade, mitotic rate, presence of atypical mitotic figures, % clear or vacuolated cells, presence of diffuse architecture, myelolipomatous change

Lymph nodes (number sampled, number with tumor)

Correlation with clinical history, laboratory findings may be helpful

 

 

Adrenal medulla

Adrenal medulla-physiology

top

Synthesizes and secretes primarily catecholamines (norepinephrine and epinephrine) in response to signals from preganglionic nerve fibers in sympathetic nervous system

Norepinephrine: local transmitter, chiefly of sympathetic postganglionic neurons

Epinephrine: systemic transmitter, interacts with alpha and beta adrenergic receptors

 

Tyrosine –1à DOPA –2à Dopamine –3à Norepinephrine –4à Epinephrine

DOPA –5à 3-methoxytyrosine –6à vanillactic acid (VLA)

Dopamine –5,6à homovanillic acid (HVA)

Norepinephrine –5à normetanephrine –6à vanilllylmandelic acid (VMA)

Epinephrine –5à metanephrine –6à vanilllylmandelic acid (VMA)

 

1: Tyrosine hydroxylase; 2: aromatic L amino acid decarboxylase; 3: dopamine beta-hydroxylase; 4: phenylethanolamine-n-methyl transferase; 5: catechol-o-methyl transferase; 6: monoamine oxidase and aldehyde dehydrogenase

 

Adrenal medullary hyperplasia

top

Defined as increase in mass of adrenal medullary cells and expansion into areas of gland not normally present, such as the tail

May cause hypertensive symptoms similar to pheochromocytoma, Cushing’s syndrome

Bilateral; either nodular or diffuse

Familial cases associated with MEN 2a, 2b/3, von Hippel-Lindau disease, neurofibromatosis type 1, familial Beckwith-Wiedemann syndrome

Sporadic cases associated with cystic fibrosis, sudden infant death syndrome, nonfamilial Beckwith-Wiedemann syndrome

Note: nodular hyperplasia in MEN 2a or 2b patients may act similar to pheochromocytomas

(Description of MEN syndromes are under Pheochromocytoma)

Diagnosis: should be based on morphometry (medullary volume > 10% of gland)

Treatment: bilateral adrenalectomy

Gross: familial cases usually have multiple unencapsulated, gray-tan nodules in both glands

Micro: alveolar, trabecular or solid patterns of medullary cells with variable size and shape; often medullary tissue in alar and tail regions of gland

Positive stains: chromogranin, synaptophysin, NSE

EM: resemble normal medullary cells

Molecular: may be monoclonal

DD: cortical atrophy making medulla appear prominent, pheochromocytoma (usually > 1 cm, increased urinary excretion of epinephrine, norepinephrine, VMA and metanephrines)

 

Adrenal medullary tumors-general

top

Broadly classified into sympathetic system tumors or adult neuroendocrine tumors

Sympathetic system tumors: neuroblastoma, ganglioneuroblastoma, ganglioneuroma; usually infants/children; occur anywhere along sympathetic chain; must differentiate from Ewing’s sarcoma/PNET

Adult neuroendocrine tumors: pheochromocytoma, adrenal medullary hyperplasia; usually adults or children with genetic syndromes

 

Malignant melanotic tumors

top

May arise from sympathetic ganglia or pheochromocytoma

Low grade tumors, may recur locally, only occasionally lead to death

DD: metastases from occult primary in skin, mucous membranes, eyes;

 

Pheochromocytoma

top

Also called paraganglioma of adrenal medulla (extra-adrenal tumors are called extra-adrenal paragangliomas)

Rare catecholamine secreting tumor (0.005% to 0.1% of unselected autopsies)

Described by Poll in 1905 as having dusky [pheo] color [chromo] of cut surface

Causes surgically correctable hypertension (also aldosterone-secreting tumors, renal artery stenosis)

Represent 0.1% of patients with hypertension, but it may be fatal

Mean age 47 years in one series, range 3-81 years

Called “10% tumor”: 10% bilateral (probably higher), 10% outside adrenal medulla, 10% metastasize (actually is probably much higher), 10% in children

Extra-adrenal tumors secrete only norepinephrine, have 20% malignancy rate

In children, usually extra-adrenal, bilateral, associated with MEN 2a/2b

Metastases usually to lymph nodes, skeletal system (ribs, spine), liver, lung; occasionally to brain, peritoneum, stomach, diaphragm, pleura, spleen, pancreas, ileum, and kidney

Occasionally associated with melanoma (Archives 1998;122:63), also neurofibromatosis, renal artery stenosis due to dysplasia, other paragangliomas, adrenal cortical tumors, von Hippel-Lindau disease

 

Familial causes of pheochromocytomas:

top

Probably more than 10% of cases; usually younger age of onset (10-20 years vs. 40-60 years), bilateral (70% vs. 10% in sporadic), multicentric, associated with other neoplasms, male gender

MEN 1: pituitary tumors, parathyroid hyperplasia or adenoma, pancreatic hyperplasia or adenoma, carcinoid tumors

MEN 2a/2: Sipple first described in 1961; autosomal dominant with high penetrance, 30-50% have pheochromocytomas, all have medullary thyroid carcinoma, 10-15% have parathyroid hyperplasia; due to mutation in RET proto-oncogene

MEN 2b/3: MEN2a signs/symptoms plus mucosal neuromas and ganglioneuromas; autosomal dominant or sporadic; may lack parathyroid hyperplasia

Sturge-Weber: cavernous hemangiomas (port-wine spots) of trigeminal nerve (cranial nerve V), pheochromocytomas

von Hippel Lindau: 10-20% of patients; cysts of kidney, liver, epididymis; renal cell carcinomas (clear cell type), pheochromocytomas, angiomas, cerebellar hemangioblastomas

von Recklinghausen (neurofibromatosis type 1): 1-5% of patients; neurofibromatosis, schwannomas, meningiomas, gliomas, pheochromocytomas; composite tumors with neuroblastoma, ganglioneuroma or ganglioneuroblastoma may be associated with neurofibromatosis 1, Mod Path 2002;15:183

 

Malignant criteria or suggestive features for pheochromocytoma

top

Most reliable is presence of metastases (lymph nodes, liver, lung, bone)

Malignant cases have MIB-1 positive cell rate of 2-3% or more (Hum Path 1998;29:522; Mod Path 1999;12:1107)

Malignant cases have strong tenascin staining (AJSP 2001;25:1419)

 

PASS score (Pheochromocytoma of the Adrenal gland Scaled Score)

top

Reference: AJSP 2002;26:551

Benign if 0-3 points, potential for malignancy if 4+ points; each feature present gets points added

1 point: vascular invasion, capsular invasion, profound nuclear pleomorphism, hyperchromasia

2 points: invasion of periadrenal adipose tissue, large nests or diffuse growth, focal or confluent necrosis, high cellularity, tumor cell spindling, cellular monotony, 4+ mitotic figures per 10 high power fields, atypical mitotic figures

 

Symptoms: related to catecholamine hypersecretion (usually norepinephrine > epinephrine); usually hypertension (abrupt; with tachycardia, palpitations, headaches, tremor, sense of apprehension, weight loss; unresponsive to treatment; isolated paroxysmal episodes of hypertension in < 50%)

Triad of sweating attacks, tachycardia and headaches is relatively specific for pheochromocytoma

Rarely associated with Cushing’s or other syndromes

Catecholamine cardiomyopathy: myocardial instability, ventricular arrhythmias; due to ischemic damage from vasoconstriction of coronaries or direct toxicity; cardiac biopsy shows myocytolysis, interstitial fibrosis, mononuclear inflammation

Diagnosis: increased urinary excretion of catecholamines or metabolites (vanilllylmandelic acid-VMA or total metanephrines); elevated serum chromogranin A levels

Treatment: surgery after premedication with adrenergic blockers

Case reports: composite tumor with pheochromocytoma, ganglioneuroma, diffuse and nodular medullary hyperplasia in MEN 2a patient (AJSP 1997;21:102); composite tumor with ganglioneuroma and separate renal angiomyolipoma (Archives 1985;109:470), bilateral pheochromocytoma-ganglioneuroma in neurofibromatosis 1 patient (AJSP 1993;17:837), with ganglioneuroma (Hum Path 1988;19:1352),  bilateral composite tumors with malignant peripheral nerve sheath tumor and GANT tumors in neurofibromatosis 1 patient (AJSP 1996;20:889), 39 year old woman with composite MPNST and pheochromocytoma (Archives 1988;112:266), pigmented tumors due to neuromelanin (Archives 2004;128:e125, Hum Path 1993;24:420, Mod Path 1993;6:175), recurrent tumor in 18 year old with family history of MEN2a and intracytoplasmic lipid droplets (Archives 1990;114:892); ACTH producing tumors (Archives 1984;108:545, Archives 1977;101:31)

Gross: small and circumscribed to large hemorrhagic and necrotic tumors (1g to 4 kg); mean 7 cm/200 g; small tumors have rim of compressed adrenal gland; lobulated; yellow-red-brown; familial tumors are bilateral and multicentric, and adjacent medulla may appear hyperplastic

Chromaffin reaction: fresh tumor turns dark brown if add potassium dichromate at pH 5-6 (Zenker’s)

Gross images: necrotic and hermorrhagic tumor; tan-red tumor; von Hippel-Lindau patient

Micro: zellballen (small nests or alveolar pattern), trabecular or solid patterns of polygonal/spindle shaped cells in rich vascular network; cells have finely granular basophilic or amphophilic cytoplasm; intracytoplasmic hyaline globules; round/oval nuclei with prominent nucleolus and variable inclusion-like structures; may have marked pleomorphism; capsular and vascular invasion common in benign behaving tumors; nests outlined by sustentacular cells (cannot see in H&E but S100+); amyloid also common (Hum Path1992;23:33); rare/no mitotic figures

Unusual morphological features: coexisting cortical hyperplasia, vacuolar degeneration of tumor cells, presence of pheochromoblasts (small cells), ganglion-like cells, calcospherites, melanin pigmentation, insular growth pattern, brown fat

May be mixed with neuroblastoma, ganglioneuroma, ganglioneuroblastoma, cortical adenoma, spindle cell sarcoma

Micro images: nests of large pink cells with prominent vasculature between nests #1#2; alveolar patternalveolar and trabecular patternstumor with delicate vasculatureabundant basophilic cytoplasmnuclear pseudoinclusions and degenerative atypiapigmented pheochromocytomanegative MelanA/A103 staining (right)various imagesKi-67 in benign and malignant paraganglioma

Virtual slides: pheochromocytoma

Positive stains: chromogranin, synaptophysin (also present in adrenal cortical carcinomas), S100 (sustentacular cells), PAS+ diastase resistant hyaline globules, tenascin (strong in clinically malignant tumors), catecholamines, neuron specific enolase, neurofilament, NESP-55 (preliminary study, AJSP 2004;28:1371), variable vimentin, bcl2, focal HMB45 (Archives 1992;116:151)

Negative stains: MelanA/Mart1, inhibin, keratin (usually), calretinin

Molecular: loss of heterozygosity (LOH) of 1p34-36 in 45%, VHL gene (3p25) in 45% (Hum Path 1997;28:411); also genetic changes in syndromes above; also mutations in genes for succinate dehydrogenase

EM: numerous membrane-bound electron dense granules containing catecholamines, tubulolamellar mitochondria, predominantly rough endoplasmic reticulum

EM images: neurosecretory granules #1; #2

DD: (small blue cell tumors): Ewing’s/PNET, small cell osteosarcoma, small cell carcinoma (neuroendocrine carcinoma), rhabdomyosarcoma, PNET/medulloblastoma, monomorphic Wilm’s tumor, neuroblastoma, carcinoid, lymphoma

DD: adrenocortical carcinoma (inhibin+, MelanA+, calretinin+, Mod Path 2003;16:591, free full text)

References: Hum Path 1987;18:909 (staining of composite tumors); Hum Path 1980;11:205 (nuclear inclusions)

 

Mixed with neuroendocrine carcinoma

top

Rare, case report at Archives 1999;123:1274

Gross image: well circumscribed mass with variegated cut surface and necrosis

Micro images: neuroendocrine carcinoma-upper left and pheochromocytoma-lower right; neuroendocrine carcinoma in vaginal wall

EM images: A: pheochromocytoma with many neurosecretory granules; B: neuroendocrine carcinoma with minimal cytoplasm, hyperchromatic nuclei, primitive cell junctions (arrows)

 

Oncocytic variant

top

Rare, case report at AJSP 2000;24:1552

Gross: solid, brown cut surface

Micro: large polygonal tumor cells with eosinophilic granular cytoplasm; arranged in nesting, alveolar, and trabecular patterns

Positive stains: chromogranin, synaptophysin, neuron-specific enolase, neurofilament, serotonin, bombesin, ACTH, vimentin, desmin, S-100, AE1/3, CAM 5.2, CK 7, CK 20

EM: closely packed mitochondria and dense-core membrane-bound granules

 

 

Neuroblastic tumors

Neuroblastic tumors-general

top

Second most common solid childhood neoplasm, after CNS tumors

15% of neoplasms in children 4 years and younger

There is a continuum from neuroblastoma (most immature) to ganglioneuroblastoma to ganglioneuroma (most mature)

 

Ganglioneuroblastoma

top

Have tumor cell differentiation between neuroblastoma and ganglioneuroma

Usually young children but also adults

Common in retroperitoneum or mediastinum (similar to ganglioneuroma) but NOT common in adrenal gland

Better prognosis than neuroblastoma

Virtual slides: ganglioneuroblastoma (not classified)

 

Nodular variant

top

Also called composite schwannian stroma rich/stroma dominant and stroma poor neuroblastic tumor, immature

Nodules may represent aggressive tumor clones

Poorer prognosis (unfavorable histology) compared to intermixed variant

Also includes case with primary tumor of ganglioneuroma or ganglioneuroblastoma, intermixed but metastases of neuroblastoma

Gross: hemorrhagic neuroblastoma nodules

Micro: abrupt demarcation of neuroblastic component (stroma poor) from ganglioneuroma (stroma dominant) or ganglioneuroblastoma, intermixed (stroma rich), with pushing borders and variable fibrous pseudocapsule; ganglioneuroma or ganglioneuroblastoma, intermixed component may be at periphery; neuroblastic component may resemble lymphocytes

 

Intermixed variant

top

Also called schwannian stroma rich neuroblastic tumor, imperfect

Favorable histology (better prognosis) compared to nodular variant of ganglioneuroblastoma

Gross: no distinct hemorrhagic nodule

Micro: random intermingling (i.e. infiltrative interface) of neuroblastic nests and ganglioneuromatous component; neuroblasts may have variable differentiation; usually abundant neuropil; ganglioneuroma / ganglioneuroblastoma component is > 50% of volume)

DD: differentiating neuroblastoma (similar, neuroblastomas have >5% ganglion cells but 50% or less ganglioneuroma / ganglioneuroblastoma component)

 

Ganglioneuroma

top

Also called schwannian stroma dominant neuroblastic tumor

Divided into maturing (also called stroma rich well differentiated neuroblastic tumor) and mature subtypes

Benign, fully differentiated neuroblastoma

Patients older than neuroblastoma

Most common neoplasm of sympathetic nervous system in adults

Usually in retroperitoneum or mediastinum (similar to ganglioneuroblastoma); less than 30% in adrenal gland

May be associated with neuroblastoma or pheochromocytoma

Often elevated serum VMA, HVA

Often severe diarrhea due to VIP secretion

Treatment: excision of ganglioneuroma mature subtype is curative, although it rarely transforms to MPNST

Gross: large, sharply circumscribed, firm with homogenous gray-white cut surface; must sample thoroughly to rule out neuroblastic differentiation (areas of different color or consistency)

Gross images: (1) well-circumscribed multinodular tumor; (2) well circumscribed gray-white tumor #1; #2; #3

Micro: resembles neurofibroma plus numerous clusters of mature ganglion cells, often multinucleated; Schwann cell component may resemble MPNST; either mature (every ganglion cell is mature, no neuroblastomatous component although may be lymphocytes) or maturing (minor component of differentiating neuroblasts or maturing ganglion cells, but no distinct nests of neuroblastomatous stroma)

Micro images: (1) clusters of ganglion cells in a neurofibroma-like background #1; #2; (3) rare case with Leydig cells; (4) ganglion cells are S100+

contributed by Professor D. Y. Cohen, Herzliyah Medical Center, Israel - retroperitoneal tumor - #1;  #2;  #3;  #4;  #5;  #6

EM: resemble sympathetic ganglion cells

DD: gangioneuroblastoma

 

Neuroblastoma

top

Also called schwannian stroma-poor neuroblastic tumor

#4 most common malignancy (solid or not) in children after leukemia, medulloblastoma/PNET, astrocytoma; rare in adults

500 new cases/year in US

Most common tumor before age 1 year; 80% are under age 4 years, median age at diagnosis is 21 months

Causes 15% of childhood cancer deaths

Screening programs detect more tumors, but don’t reduce mortality (Int J Cancer 2003;103:538)

Derived from neural crest cells capable of multilineage differentiation

25% occur in adrenal medulla, also along sympathetic chain (neck, posterior mediastinum, paravertebral, retroperitoneum)

Associated with Beckwith-Wiedemann syndrome, Hirschsprung’s disease, neurofibromatosis type 1, fetal hydantoin syndrome, opsoclonus/myoclonus, heterochromia iridis, Cushing’s syndrome

Maturation: 30% regress or mature to ganglioneuroma; maturation associated with high numbers of Schwann cells that migrate into tumor, express high levels of NGF receptors p140 TrkA and p75 NGFR, and induce differentiation

For children age 1+, some neuroblastomas make trophic factor for Schwann cells, leading to inward migration of Schwann cells, leading to TrkA expression, leading to tumor cell differentiation

For children less than age 1, neuroblastomas don't make trophic factor for Schwann cells, causing apoptosis

May also differentiate into ganglioneuroblastoma

Clinical: young children present with large abdominal masses that may fill abdomen or thorax, fever, weight loss; usually increased levels of catecholamines, but without symptoms

Usually adrenal, but 1/3 in head and neck, mediastinum or pelvic area

Older children may present with bone pain, respiratory or GI complaints due to metastatic disease

Spreads to adjacent tissue including kidney, spine (dumbbell extension)

Metastases are usually early and widespread to bone marrow, bones (skull or orbit; multiple, often symmetrical), lymph nodes, meninges, liver (Pepper’s syndrome), ovary, paratesticular region; lung and brain uncommon

High urinary catecholamines

Survival: 3 year overall survival is 30%

5 year survival (data several years old): age < 1 year old and stage I/II: 95-98%; <1 year old and stage IV-S: 80%

<1 year old and stage IV: > 50%; > 1 year old and stage III/IV: 10%

Treatment: surgery, chemotherapy, bone marrow transplantation

Case reports: metastatic disease with pheochromocytoma differentiation after surgery and chemoradiotherapy (AJSP 2004;28:548), presentation as primary ovarian tumor (AJSP 1982;6:283, patient #5), association with anencephaly (Archives 1979;103:119)

Gross: varies from in situ lesions (minute nodules) to 1 kg; usually well circumscribed but may be infiltrative; composed of soft, gray-pink, brain-like tissue; well differentiated tumors are yellow-tan and resemble ganglioneuroma; large tumors have hemorrhage, necrosis, calcification, cysts; 90% unilateral; may be locally invasive to liver or pancreas

Gross images: (1) right sided neuroblastoma displacing liver; (2) encapsulated tumor; (3) pink-gray tumor; (4) necrotic and hemorrhagic tumor; (5) post-chemotherapy

Micro: vaguely nodular due to incomplete fibrous encapsulation; small blue cell tumor (minimal cytoplasm, hyperchromatic round nuclei), with poorly defined cytoplasmic borders; 25-35% have Homer-Wright pseudorosettes (tumor cells surround central space filled with fibrillar extensions [neurites] of cells without a central lumen); may have neuropil (fine fibrillary matrix) between tumor cells; may have alveolar, pseudovascular or Schiller-Duvall body appearance due to hemorrhage; may have prominent calcification; necrosis common; rarely has “zellballen” appearance or bizarre tumor giant cells

INPC classification of neuroblastoma:

Classic (undifferentiated) neuroblastoma: also called grade III/IV or stroma-poor; small/medium cells with thin rim of cytoplasm, indistinct cell borders, round/oval nuclei with salt and pepper (coarsely granular) chromatin, indistinct nucleoli; no neuropil, although coagulative necrosis may resemble neuropil; 5% or less of tumor has features of differentiation towards ganglion cells with vesicular nuclei and prominent nucleoli; no/minimal ganglioneuromatous stroma

Poorly differentiated neuroblastoma: classic pattern but with neuropil

Differentiating neuroblastoma: 6-49% of tumor cells show ganglionic differentiation (abundant eosinophilic or amphophilic cytoplasm, large eccentric nuclei with vesicular chromatin and single prominent nucleoli), often at periphery of tumor; if 50% or more, call ganglioneuroblastoma, intermixed); usually abundant neuropil

Mitotic karyorrhexis index: number of karyorrhectic cells based on 5000 cell counts in random fields; either low (<100), intermediate (100-200) or high (>200)

Note: diagnosis of “neuroblastic tumor unclassifiable” may be appropriate for small biopsies; “neuroblastoma, NOS” may be appropriate if poor histologic sections, hemorrhage, necrosis, crush, cystic degeneration or marked calcification

Micro images: low power; undifferentiated neuroblastoma; various images

Virtual slides: neuroblastoma

Positive stains: chromogranin, synaptophysin, vimentin, neurofilament, neuron-specific enolase (monoclonal antibody is more specific), nerve growth factor receptors, ALK

Negative stains: p53, CD99, FLI1, desmin, myogenin, keratin, CD45, variable EMA, variable WT1

Molecular: 1p36.33 deletion, N-myc amplification, 14p deletion, 17q gain, diploid or hyperdiploid, TrKA gene expression abnormalities

EM: neurosecretory granules, synaptic endings, neurites forming complex interdigitating meshwork in center of Homer-Wright pseudorosettes, neuropil represents mass of unmyelinated axons

EM images: neurosecretory granules

DD: rhabdomyosarcoma (strap cells, rhabdomyoblasts, muscle marker+), Ewing’s/PNET (usually does not present with metastatic disease, older children, no neuropil, CD99+, chromogranin-), lymphoma, desmoplastic small round cell tumor, monophasic Wilm’s tumor (none have differentiation towards immature ganglion cells)

 

Neuroblastoma in situ

top

Usually incidental finding at autopsy in 0.4 to 2.5% of infants less than 3 months

May not be neoplastic or may mature into ganglioneuroma

Micro: clusters of immature neuroblasts from 0.7 to 9.5 mm, with frequent cystic change

 

Treatment effect

top

Cannot grade tumors as favorable or unfavorable

Micro: extensive fibrosis and calcification may obscure margin involvement; also necrosis and chronic inflammation

 

Staging of neuroblastic tumors

top

Evans staging of neuroblastomas

I - tumor confined to structure or organ of origin

II - tumor extends in continuity beyond structure or organ of origin, doesn't cross midline, variable ipsilateral nodal metastases

III - tumor extends in continuity beyond midline; variable bilateral nodal metastases

IV - tumor metastatic to viscera, distal lymph nodes, soft tissue, skeleton

IV-S (special) - stage I or II with remote disease in liver, skin, bone marrow (with no bony destruction)

 

Stage IV-S (4S): small/undetectable primaries with disease involving liver, skin or bone marrow; survival of 60-90%; median age 4 months, primary usually adrenal (also retroperitoneum, mediastinum); usually have favorable histology; patients dying of progressive disease have either unfavorable histology or N-myc amplification (Hum Path 1996;27:1135)

 

Ten year survival by Evan’s stage: I-88%, II-90%, III-63%; IV-21%, IVs-81%

 

International neuroblastoma staging system (INSS)

top

1 - localized tumor with complete gross (not necessarily microscopic) excision, negative representative ipsilateral lymph nodes microscopically; note: nodes removed with primary tumor may be positive; includes grossly resectable tumor in midline from pelvic ganglia or organ of Zuckerkandl

2A - localized tumor with incomplete gross excision, negative representative non-adherent ipsilateral lymph nodes microscopically; note: includes midline tumor that extends beyond one side of vertebral column and is unresectable

2B - localized tumor with positive representative non-adherent ipsilateral lymph nodes; enlarged contralateral lymph nodes must be negative microscopically; note: includes midline tumor that extends beyond one side of vertebral column, is unresectable with positive ipsilateral lymph node involvement (on side of extension); also includes a thoracic tumor with malignant unilateral pleural effusion

3 - unresectable unilateral tumor infiltrating across midline or localized unilateral tumor with contralateral regional lymph node involvement; note: includes midline tumor with bilateral extension by infiltration (unresectable) or by lymph node involvement; includes a tumor of any size with malignant ascites or peritoneal implants

4 - any primary tumor with dissemination to distant lymph nodes, bone, bone marrow, liver, skin or other organs (except 4S)

4S - localized primary tumor (stage 1, 2A or 2B) with dissemination limited to skin, liver or bone marrow (limited to infants < 1 year of age); note: marrow involvement should be minimal (<10% of total nucleated cell identified as malignant); more extensive involvement should be classified as stage 4

Note: for infants < 1 year, stages 1, 2A, 2B, 3 and 4S have similar rates of 4 year overall survival (98.5%) compared to stage 4 (73%

 

Prognostic factors for neuroblastic tumors

top

Poor prognostic indicators:  1p36.33 deletion (subtelomeric region, may be site of differentiation associated genes); N-myc amplification (>10 copies, is associated with 1p36 deletion), 14p deletion, diploidy, low expression of TrkA gene (maturation factor), undifferentiated morphology, high mitotic rate-karyorrhexis index and age 1 year old or more; this group has a 5% cure rate; also 17q+, elevated serum ferritin (> 150 ng/mL)

Note: the more copies of N-myc, the greater the number of double minutes and homogenously staining regions, and the worse the prognosis

Favorable prognostic indicators: age < 1 year regardless of stage, hyperdiploid / near-triploid, high levels of TrkA gene (associated with lack of N-myc amplification), stages 1, 2 or 4S versus stages 3 or 4

Intermediate prognostic indicators: near-diploid/tetraploid, no N-myc amplification, no 1p deletions, low levels of TrkA; older patients; this group has a 25-50% cure rate

 

Shimada classification:

top

Features include age, degree of neuroblast differentiation, presence or absence of Schwannian stromal development (stroma-rich or stroma-poor), mitosis-karyorrhexis index (MKI), nodular pattern

Stroma rich: significant number of Schwann cells in association with neuroblastoma cells-corresponds to ganglioneuroblastoma

Stroma poor: undifferentiated or differentiated neuroblastoma

Mitosis-karyorrhexis index (MKI): count of cells undergoing mitosis or karyorrhexis, based on count of 5000 cells; either low (<100 cells), intermediate (100-199 cells) or high (200 or more cells)

Note: the unfavorable histologic features are reported inconsistently by various sources

 

Favorable histology group:

(a) patients of any age with stroma-rich tumors without a nodular pattern

(b) patients younger than 18 months, with stroma-poor tumors, an MKI less than 200/5000 (200 karyorrhectic cells per 5000 cells scanned) or

(c) patients 18-60 months with stroma-poor tumors, an MKI less than 100/5000, and well-differentiated tumor cells

 

Unfavorable histology group:

(a) patients of any age with stroma-rich tumors and a nodular pattern

(b) patients of any age with stroma-poor tumors and an MKI more than 200/5000

(c) patients 18-60 months with stroma-poor tumors, differentiated neuroblasts, and an MKI of 100-200/5000

(d) patients 18-60 months with stroma-poor tumors, undifferentiated neuroblasts

(e) patients older than 60 months with stroma-poor tumors

 

 

Joshi classification of neuroblastoma:

top

Grade 1: <10 MF/10 HPF and calcification - good prognosis (5 year survival of 89%)

Grade 2: < 10 MF/10 HPF or calcification, but not both - intermediate prognosis (5 year survival of 77%)

Grade 3: >10 MF/10 HPF and no calcification, any age - poor prognosis (5 year survival of 33%)

 

International Neuroblastoma Pathology Committee (INPC)

top

Four major categories: (1) neuroblastoma (schwannian stroma-poor neuroblastic tumor), (2) ganglioneuroblastoma, nodular (composite schwannian stroma-rich/stroma dominant and stroma-poor neuroblastic tumor), (3) ganglioneuroblastoma, intermixed (schwannian stroma-rich neuroblastic tumor), (4) ganglioneuroma (schwannian stroma-dominant neuroblastic tumor)

 

Favorable histology categories for neuroblastoma include: poorly differentiated, low or intermediate MKI, age < 1.5 years; or differentiating, low MKI, age 5 years or less; or differentiating, intermediate MKI, age < 1.5 years

All other neuroblastomas are unfavorable histology

Overall 5 year survival was 97.8% for favorable versus 35.6% for unfavorable histology groups for neuroblastoma

Ganglioneuroblastoma-intermixed and ganglioneuroma were considered to have favorable histology, and had 100% overall 5 year survival

Ganglioneuroblastoma-nodular was considered to have unfavorable histology, and had 59% overall 5 year survival

 

Grossing possible neuroblastic tumors

top

Presence of absence of capsule

Resection margins

Include all heterogeneous areas and interface between them

Cytogenetics

Molecular genetics

EM

 

 

Other adrenal malignancies

Angiosarcoma

top

Very rare

6-10 cm

Spindled or epithelioid

Case reports: 54 year old man (Archives 1988;112:1163)

Positive stains: factor VIII related antigen, CD34

 

Epithelioid angiosarcomas

top

Rare

Median age 60 years, range 45-85 years; no gender preference

Aggressive, with death common due to lung metastases

Treatment: excision, chemotherapy

Case reports: epithelioid angiosarcoma (Archives 1999;123:157)

Gross: 6-10 cm; may be cystic-solid

Micro: sheets or nests of epithelioid cells between dilated anastomotic vascular spaces lined by similar cells; tumor cells have intracytoplasmic vacuoles occasionally containing red blood cells

Positive stains: Factor VIII related antigen, CD31, CD34, Ulex europaeus, keratin, B72.3

EM: rod-shaped microtubulated bodies, intracytoplasmic lumen

DD: hemorrhagic infarction of adrenal adenoma with atypical fibroblasts

References: AJSP 1994;18:62

 

Ewing’s sarcoma/PNET

top

Case report of adrenal tumor in 11 year old Japanese boy (Hum Path 2001;32:1012); patient died 15 months after presentation despite aggressive treatment

Micro: monotonous primitive round cells resembling neuroblastoma

Positive stains: CD99/MIC2

Molecular: t(11;22)(q24;q12) and EWS-FLI1 gene fusion product
DD: neuroblastoma (MIC2/CD99 negative, no Ewing’s/PNET translocation)

 

Leiomyosarcoma

top

Associated with Epstein-Barr virus infection in HIV+ patients (Archives 1997;121:834)

May arise from smooth muscle wall of central adrenal vein

Case reports: 49 year old man with 11 cm tumor, necrosis and prominent mitotic figures (AJSP 1991;15:899), 30 year old HIV+ man (Archives 1995;119:1164), 63 year old man with pleomorphic leiomyosarcoma (Archives 2003;127:e32)

Micro images: pleomorphic leiomyosarcoma - 1: multinodular mass adjacent to kidney; 2: tumor invades liver; 3: pleomorphic tumor cells; 4: bizarre tumor cells and abnormal mitotic figures; 5: desmin+; 6: calponin+

 

Lymphoma

Primary adrenal lymphoma

top

Rare, <100 cases reported

Usually present with bilateral adrenal masses, often with adrenal hypofunction

Usually diffuse large B-cell lymphomas

Case reports: cytokeratin+, CD45 negative, diffuse large B cell lymphoma (Archives 2001;125:1104), primary diffuse large B cell lymphoma (Archives 1990;114:883), bilateral angiotropic large cell lymphoma (Archives 1991;115:1039), bilateral T cell lymphoma causing adrenal insufficiency (Hum Path 1986;17:634)

Micro images: diffuse large B cell lymphoma

 

Secondary adrenal lymphoma

top

Adrenal involvement occurs at autopsy in up to 25% with disseminated lymphoma

Usually no associated adrenal insufficiency

 

Metastases

top

Common at autopsy, usually bilateral

Most common primary sites are breast or lung; also melanoma, renal cell carcinoma, GI tract, thyroid, contralateral adrenal gland

Usually does not affect adrenal function; may cause adrenal insufficiency if extensive (replacing 80%+ of adrenal gland)

Gross: single or multiple firm masses replacing some or all of adrenal gland; hemorrhage and necrosis in larger metastases; tumors are tan-brown to black

Gross images: unknown metastases

DD: adrenal cortical carcinoma (melanA+, inhibin+, calretinin+, synaptophysin+, keratin-, EMA-, metastases are usually opposite)

 

Plasmacytoma

top

Very rare in adrenal gland, with < 5 cases reported

Must exclude myeloma (negative bone marrow biopsy, no hypercalcemia, anemia or renal insufficiency)

Case report of adrenal gland tumor (Archives 2004;128:e86)

Micro images: A: MRI shows 3.5 cm adrenal mass; B: well circumscribed plasma cell tumor adjacent to benign adrenal cortical tissue; plasma cells are large and atypical; C: CD138+; D: gamma light chain positive

 

 

Paraganglia

Paraganglia-general

top

Neural crest origin

Paraganglion system is formed by neuroepithelial chief cells scattered throughout the body in 3 chains (branchiomeric, intravagal, aorticosympathetic), associated with the sympathetic [epinephrine secreting] or parasympathetic [norepinephrine secreting] nervous system; also present in viscera

Sympathetic paraganglia are paravertebral and paraaortic; parasympathetic are in head and neck

Terminology based on site of origin, not secretory products

Chief cells are arranged in well-defined nests (zellballen) surrounded by rim of sustentacular cells

Chief cells have cytoplasmic neurosecretory granules containing catecholamines; cannot determine function of cells by their appearance

Are called chromaffin cells because they stain yellow-brown with chromium salts

Adrenal medulla is considered part of paraganglion system

Positive stains: chief cells - synaptophysin and chromogranin; sustentacular cells - S100

 

Branchiomeric chain: associated with parasympathetic nervous system, along jugular vein, vagus, larynx

Intravagal chain: associated with parasympathetic nervous system; distributed along vagus nerve

Aorticosympathetic chain: associated with sympathetic nervous system; along abdominal aorta

Organ of Zuckerkandl: between renal artery and aortic bifurcation, part of aorticosympathetic group; first described by Emil Zuckerkandl in 1901 (University of Vienna); may maintain blood pressure in early fetal life, involutes after 8th month of gestation

Visceral paraganglia: within bladder, other organs

Carotid body paraganglia: part of branchiomeric system; small ovoid structure on medial side of carotid bifurcation bilaterally; mean total weight is 12 mg; chemoreceptors that respond to changes in arterial O2, CO2 and pH

Glomus coccygeum: also called Luschka’s gland; small (2.5 mm), ovoid vascular structure near tip of coccyx; composed of epithelioid cells in layers around vascular channels; no known function

Micro drawings: carotid bodies; glomus coccygeum

 

Hyperplasia

top

Hyperplasia is most commonly seen in carotid bodies, and is associated with high altitude, chronic obstructive pulmonary disease, systemic hypertension, cystic fibrosis, cyanotic congenital heart disease

May also affect vagal and aorticopulmonary paraganglia

High altitudes are also associated with carotid body paraganglioma

Mechanism is presumably due to chronic hypoxemia

Gross: weight over 30g, diameter > 5 mm

Micro: increased number of lobules, some confluent, composed of increased numbers of sustentacular cells and chief cells with hyperchromatic and mildly enlarged nuclei

DD: paraganglioma (usually > 300 mg, have higher density of chief cells)

 

Paraganglioma-general

top

Tumors of paraganglia, regardless of location, although paraganglioma of adrenal medulla is termed pheochromocytoma

5-10% occur outside adrenal gland

Associated with von Hippel-Lindau disease, MEN syndromes, Carney’s syndrome, neurofibromatosis type 1

20% are multiple versus 10% for sporadic pheochromocytomas

10-40% are malignant, may recur or metastasize to regional lymph nodes, bone, liver, lung; may cause death

May have cardiovascular symptoms due to toxic effect of norepinephrine on myocardium

Chemodectoma: carotid and aortic body tumor (tumors of paraganglia with a chemoreceptor function)

Familial cases: autosomal dominant with paternal imprinting, linkage to 11q23 and 11q13, usually carotid body paragangliomas, also other sites

Sympathoadrenal paragangliomas are associated with MEN 2a and 2b

Poor prognostic features (malignant behavior): Organ of Zuckerkandl (22%-50% vs. 10%+ in adrenal gland), high mitotic activity; possibly necrosis and vascular invasion; only definitive criteria for malignancy is presence of tumor at site where no normal paraganglionic tissue exists

Case reports: mesenteric paraganglioma (Archives 2002;126:362), organ of Zuckerkandl (Archives 2001;125:1387), retroperitoneal tumor with liver metastases 23 years after resection (Archives 1985;109:373)

Gross: rubbery, firm, may have pseudocapsule, but adherent to adjacent vessels; brown cut surface; variable central scar

Gross images: retroperitoneal tumor #1; #2

Micro: same as pheochromocytoma; nesting (zellballen) or trabecular pattern of cells within a prominent vascular network; zellballen pattern may be obscured by anastomosing bands; nests composed of round/oval cells and giant multinucleated cells with abundant granular eosinophilic or basophilic cytoplasm, may have nuclear atypia and vascular invasion (don’t indicate malignancy); dysmorphic vessels, melanin-like pigment, abundant stroma, osseous metaplasia; intracytoplasmic hyaline globules are present in sympathoadrenal paragangliomas; no mitotic figures except in obviously malignant tumors; no rosettes or acini; usually no chronic inflammatory infiltrate, no necrosis (unless preoperative tumor embolization)

Cytology: irregular clusters of tumor cells with eosinophilic, finely granular cytoplasm and mildly irregular nuclei; may have marked atypia; fine needle aspiration not recommended for carotid body paragangliomas due to high likelihood of misinterpretation and risk for catecholamine crisis and hemorrhage

Micro images: (1) various images of retroperitoneal primary and metastases to stomach and lymph node; (2) encapsulated mass with zellballen pattern #1; #2

Micro images: Ki-67 in benign pheochromocytoma (top) and malignant paraganglioma (bottom)

Stains: same as pheochromocytoma; reticulin highlights nesting pattern; cauda equina tumors are usually keratin negative

Molecular: LOH of 3p21 in 50% in small study (Hum Path 1997;28:411)

EM: chief cells have abundant cytoplasmic neurosecretory granules; may have giant mitochondria with paracrystalline inclusions; sustentacular cells wrap around chief cells and lack neurosecretory granules; no desmosomes

DD: alveolar soft parts sarcoma, MFH, alveolar rhabdomyosarcoma, liposarcoma, melanoma, metastatic carcinoma of kidney, thyroid, adrenal medulla and liver; carcinoid tumors, pancreatic endocrine neoplasms

 

Aorticopulmonary paraganglioma

top

Usually arise from paraganglia near base of heart or above aortic arch

May cause hoarseness, dysphagia, chest pain/discomfort; rarely hemoptysis or superior vena cava syndrome

May directly involve pericardium or heart

Case reports: 41 year old man with nonfunctioning mediastinal tumor discovered incidentally (Archives 1992;116:1085)

Gross: large, mean 7.5 cm (range 1-17 cm)

 

Carotid body paraganglioma

top

Most common site of extra-adrenal paragangliomas

Present at angle of mandible / bifurcation of common carotid artery as slow growing painless mass

May represent hyperplasia due to hypoxia, particularly at high altitudes

Also associated with hepatic cirrhosis, Carney’s triad (epithelioid leiomyosarcoma, pulmonary chondroma, functioning extra-adrenal paragangliomas)

May cause cranial nerve palsy, dysphagia or carotid sinus syndrome (bradycardia and syncope)

Rarely produces catecholamines

Mean age 40’s

90% benign, 90-95% solitary

May invade locally or spread to lymph nodes or lung (must rule out multicentric tumor)

Adherent to carotid bifurcation, but this does not represent malignant infiltration

May be familial (Archives 1990;114:1272)

Case reports: lung metastases in patient with von Hippel-Lindau disease (Archives 1982;106:235)

Treatment: excision

Gross: mean 4 cm, range 2-8.5 cm

References: functional tumors (Archives 1982;106:599)

 

Cauda equina paraganglioma

top

Rare; may attach to filum terminale or caudal nerve roots

Age 30’s to 60’s

Case reports: tumor with ependymal and paraganglionic differentiation (Hum Path 1992;23:835)

Gross: usually intradural, extramedullary, encapsulated

Micro: may have neuronal or ganglionic differentiation similar to ganglionic paraganglioma or composite paraganglioma

Positive stains: NSE, neurofilament; S100 for sustentacular cells

DD: ependymoma

 

Jugulotympanic paraganglioma

top

Previously called glomus jugulare tumors

Usually arise lateral in temporal bone (glomus tympanicum tumor) or jugular bulb (glomus jugulare tumor), erode through floor and present as mass of external auditory canal or middle ear; also mass at base of skull, middle ear “polyps”

40% extend into cranial cavity

Usually adults, almost always women

Similar morphology as other paragangliomas, but often removed in small fragments

Often misidentified as hemangiomas due to fragmented specimens

Malignant cases often involve bone

Treatment: surgery, external beam radiation therapy

Case reports: metastatic tumor (Archives 1990;114:976)

 

Laryngeal paraganglioma

top

Rare; usually arise from superior paraganglia

Mean age 47 years

Hoarseness and dysphagia

25% mortality; often tender subcutaneous metastases

Gross: 2-5 cm

EM: neurosecretory granules

DD: atypical carcinoid tumor

References: AJSP 1979;3:85

 

Mediastinal paraganglioma

top

Usually in anterosuperior mediastinum near aortic arch; also in costovertebral sulcus

Aggressive behavior with substantial morbidity or death in 45% in one study

 

Organ of Zuckerkandl paraganglioma

top

Close to normal location of this structure, near anterior wall of aorta and origin of inferior mesenteric artery

May invade inferior vena cava

Micro: often nuclear pseudoinclusions (invagination of cell cytoplasm)

 

Pigmented paraganglioma

top

Rare

Case report of incidental retroperitoneal tumor in 57 year old woman (AJSP 1998;22:265)

Gross: jet-black or no gross evidence of pigmentation

Micro: pigment consistent with neuromelanin, a waste product of catecholamine metabolism

EM: dense core neurosecretory granules, usually melanosomes or premelanosomes; case report above had abundant large pleomorphic electron dense granules consistent with lipofuscin or neuromelanin

DD: melanoma

 

Vagal paraganglioma

top

Usually women in 30’s and 40’s

Near neck, jugular foramen with extension to base of skull

May cause deviation of palatine tonsil or vagus nerve palsy with hoarseness and dysphagia

Gross: usually well circumscribed, but may invade locally; mean 4 cm, range 2-6 cm

Micro: often prominent hyalinized fibrous septa

 

Paragangliomas – features to report

top

Excludes pheochromocytomas

 

Site of origin

Bilateral or not

Familial or sporadic (based on clinical history)

Tumor size / weight

Histologic type, with brief reference to clinical or endocrinologic data

Composite features (ganglioneuroma, MPNST, other)

Extent of tumor necrosis

Extent of mitotic activity

Other prognostic features (invasion of adjacent tissue, angiolymphatic invasion)

Surgical margins

Other features

Regional lymph nodes (# involved/# inspected)

References: Hum Path 2003;34:112

 

End of Adrenal Gland chapter

top

 

Jobs-Pathologist/PhD

Jobs-Laboratory/Other

Fellowships

Conferences

Books

Affiliates

 

Home page